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Abstract 
Osteoarthritis (OA) is a chronic, progressive disease of diarthrodial joints 
arising from the breakdown of articular cartilage. As one of the leading causes of 
disability and lifestyle limitations in the United States, osteoarthritis is estimated 
to affect 27 million people in the U.S. and cost the economy $128 billion annually. 
Current diagnostic techniques detect OA only in its later stages, when 
irreversible cartilage damage has already occurred. A reliable, non-invasive 
method for diagnosing OA in its early stages would provide an opportunity to 
intervene and potentially to stay disease progression. Likewise, the field of OA 
research would benefit from a technique that allows tissue engineering and small 
molecule therapies to be evaluated longitudinally. 
Contrast-enhanced computed tomography (CECT) of cartilage is a 
developing medical imaging technique for evaluating cartilage biochemical and 
viii 
biomechanical properties. CECT has been shown to accurately quantify measures 
of cartilage integrity such as glycosaminoglycan (GAG) content, equilibrium 
compressive modulus, and coefficients of friction. 
In the studies presented herein, cationic iodinated contrast agents are 
developed for quantitative cartilage CECT, a technique predicated on the 
diffusion and partitioning of a charged contrast agent into the cartilage. The 
experiments show that cationic contrast agents lack specific interactions with 
anionic GAGs and are highly taken up in cartilage due, instead, to their 
electrostatic attraction. At diffusion equilibrium, both anionic and cationic agents 
indicate GAG content and biomechanical properties as measured by micro-
computed tomography, though cationic contrast agents were found to diffuse 
through cartilage more slowly than anionic ones. Translating CECT to intact 
joints with clinically available helical CT scanners bears promising results, but 
concerns remain regarding in vivo applicability. Anionic contrast agents enable 
GAG content quantification following brief contrast agent exposure, whereas 
cationic agents require full equilibration within the tissue. 
To explore treatment modalities for early OA, a novel interpenetrating 
hydrogel method was developed to reconstitute the mechanical properties of 
cartilage models for early OA. Preliminary results show that the interpenetrating 
ix 
network strengthened cartilage with respect to compressive loading~ suggesting 
that the treatment could potentially serve as a functional replacement for GAG 
lost in the early stages of OA. 
X 
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Chapter 1: Introduction 
1.1 Motivation 
Among the broad array of diseases and disorders attended to by modern 
clinical practice, chronic conditions consume the majority of healthcare resources 
and cause the most death and disability. The Centers for Disease Control report 
heart disease, stroke, diabetes, cancer, and arthritis as "the most common, costly, 
and preventable of all health problems in the U.S."1. As one of the leading causes 
of disability and lifestyle limitations in industrialized countries, arthritis is 
estimated to cost the U.S. economy $128 billion annually2• Further, its prevalence, 
in an aging population (1 in 5 adults currently experience some form of doctor-
diagnosed arthritis, including 1 in 2 adults over age 652) makes it a crucial 
healthcare concern. Among the types of arthritis, osteoarthritis (OA) is by far the 
most common, affecting 27 million people in the United States alone2• 
One critical challenge for clinicians charged with ameliorating OA is that 
current diagnostic techniques (plain radiography, patient-reported symptoms 
such as pain, swelling, joint instability and decreased range of motion) detect OA 
only in its later stages, when irreversible cartilage damage has already occurred. 
A reliable, non-invasive method for diagnosing OA in its early stages could 
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provide opportunities to treat the disease before it progresses. Likewise, a 
technique for longitudinally monitoring disease progression and therapeutic 
response in affected patients (and in animal models used for preclinical OA 
therapy research) would be an invaluable tool. 
Contrast-enhanced computed tomography (CECT) of cartilage is a 
developing medical imaging technique for evaluating cartilage health both 
qualitatively and, more recently, quantitatively. In addition to elucidating 
morphological parameters (e.g. tissue thickness, presence of lesions, etc.), CECT 
has been shown to accurately quantify glycosaminoglycan (GAG) content in 
cartilage3-10• GAGs are an important component of the extracellular matrix (ECM) 
in cartilage since they produce a negative fixed charge density, which in turn 
maintains tissue hydration and affords resistance to compressive loads11 • GAG 
loss is an early event in OA. CECT quantification of GAG is predicated on the 
diffusion and equilibrium partitioning of a charged iodinated contrast agent into 
the cartilage. Currently, anionic contrast agents are used that partition in inverse 
proportion to GAG content due to electrostatic repulsion3-6,IO. 
In 2008, a suite of cationic contrast agents was developed by a team of 
chemists and biomedical engineers in the Grinstaff Group at Boston University. 
Since the cationic contrast agents will operate according to electrostatic attraction 
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rather than repulsion, it was hypothesized that they would perform better for 
quantitative CECT than commercially available anionic agents. Several 
preliminary studies did indeed show that the cationic agents are able to 
quantitatively indicate GAG content7·12•13• Likewise, contemporary reports using 
both cationic and anionic contrast agents have shown that biomechanical 
measures of cartilage integrity (equilibrium compressive modulus and 
coefficients of friction) can also be quantified using CECT6•14• Indeed, these 
finding are important since cartilage mechanical performance may be a superior 
indicator of proper functioning and relative disease state. 
1.2 Thesis Objectives 
In the following studies, CECT using cationic iodinated contrast agents is 
further developed for the quantitative measurement of cartilage health. The main 
hypotheses driving the investigations were: 
Hypothesis 1: Owing to their electrostatic attraction to GAGs, cationic 
contrast agents will be highly taken up in cartilage and will enable sensitive 
quantification of GAG content as well as biomechanical properties of healthy and 
degenerated articular cartilage using high-resolution CT instrumentation. 
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Hypothesis 2: CECT imaging will be also be efficacious using clinically 
available helical CT scanners, though translation of the technique to the clinical 
scale could be complicated by concerns such as decreased scanner resolution and 
slow contrast agent diffusion through the relatively thick cartilage tissues in 
large animals and human. 
Having addressed these hypotheses, a novel treatment for OA in its early 
stages was also developed and preliminarily characterized. If CECT is to be 
clinically useful for identifying early-stage cartilage pathologies, companion 
treatments must be concurrently developed which mitigate the disease or delay 
its progression. In these experiments, healthy and degraded cartilage specimens 
were treated with an interpenetrating hydrogel intended to reinforce the 
mechanical performance of the tissue. In these efforts, the hypothesis was that: 
Hypothesis 3: An interpenetrating hydrogel network will restore the 
mechanical function of degraded cartilage to that of healthy tissue, which could 
have utility as a treatment for early-stage (GAG-depleted) OA cartilage. 
To address these hypotheses, Chapter 2 begins by providing a thorough 
background account of OA, cartilage structure and function, and quantitative 
imaging of cartilage, including CECT. In Chapter 3, a series of ex vivo 
experiments are presented in bovine (cow) and leporine (rabbit) articular 
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cartilage, which demonstrates the promising CECT quantification of GAG 
content using cationic contrast agents compared to commercially available 
anionic agents. Chapter 4 presents preliminary evidence in a rabbit model that in 
vivo CECT may be indicative of cartilage degeneration. This study, additionally, 
reveals some of the key challenges in applying CECT to tissues in vivo. Since an 
understanding of the mechanism of interaction between cationic contrast agents 
and anionic GAGs is imperative for developing a robust quantitative technique, 
Chapter 5 investigates contrast agent partitioning and diffusion through articular 
cartilage. Special attention is paid to indicators of binding interactions, of which 
none were observed. Chapter 6 begins the development of CECT as a clinical tool 
by measuring the capability of both anionic and cationic contrast agents to 
indicate GAG content and mechanical properties using both high-resolution 
micro-computed tomography (j.lCT) and conventional helical CT available in 
clinical settings. The study showed that while j.lCT was strongly quantitative, the 
clinical CT scanner lacked sufficient spatial resolution to accommodate the 
cartilage region-of-interest size. In Chapter 7, these findings were expanded by 
comparing j.lCT and clinical CT in an equine (horse) model for both healthy and 
degenerated cartilage. These experiments suggest that CECT quantification in 
equine joints may be possible, but translation to equine veterinary practice 
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requires further study. Principally, equine and human cartilage is relatively thick 
and may not reach diffusion equilibrium within a clinically acceptable time 
frame. Although CECT measured at diffusion equilibrium has produced 
favorable results, the technique will be markedly more useful if it can produce 
sensitive and accurate quantification prior to diffusion equilibrium. Therefore, 
Chapter 8 retreated from clinical CECT imaging to evaluate the ability of cationic 
and anionic contrast agents to indicate GAG content prior to diffusion 
equilibrium. In a simulated in vivo diffusion environment, an anionic contrast 
agent partitioned in cartilage proportionally to GAG content prior to diffusion 
equilibrium, a cationic contrast agent did not. Additionally, the diffusivity of 
both contrast agents was slow relative to what would be considered an 
acceptable diffusion time in a clinical protocol. Given these results, 
recommendations for the future of CECT are provided. Finally, Chapter 9 
switches gears from a focus on CECT and explore a novel technique for 
reinforcing degenerated cartilage. To put CECT in proper context, it is important 
to acknowledge that even if CECT is efficacious for OA diagnosis, its utility will 
be diminished if clinicians are not enabled to treat the early-stage disease. In 
these experiments, a novel interpenetrating hydrogel treatment technique 
improves the mechanical performance of articular cartilage, although many 
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further studies are required to fully characterize and validate the treatment 
system. 
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Chapter 2: Background 
2.1 Articular cartilage structure and function 
Hyaline cartilage, the cartilage type that lines articular joints, is a smooth, 
hydrated tissue that functions to distribute loads and lubricate motion. 
Comprised of 68-85% water, 10-20% collagen (primarily type II with smaller 
amounts of XI, VI and IX collagens), and 5-10% proteoglycans11, cartilage is 
structurally anisotropic. In the superficial zone (the surface 10% of total 
thickness), tangentially oriented collagen fibrils resist shear forces that are 
applied during joint motion. The proteoglycan content of the superficial zone is 
relatively low. In the middle zone, collagen content is lower and fibrils are more 
randomly oriented while proteoglycan and water content are increased15 • 
Proteoglycan and water contents are high in both the middle and deep zones, 
since the proteoglycan side-chains (glycosaminoglycans, GAGs) and water are 
primarily responsible for cartilage's unique capacity to resist compressive 
loads16,17• 
The particular composition of each cartilage extracellular matrix (ECM) 
zone provides a specific mechanical function. The superficial zone functions to 
resist tensile or shear loads as well as lubricate motion at the articular surface. 
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The middle and deep zones are responsible for resistance to compressive loads. 
The porous nature of middle and deep zone ECM retains and regulates water; in 
fact, upwards of 90% of an applied load is supported by pressurization of 
entrapped interstitial water1s-20• GAGs in the ECM are negatively charged 
sulfated and carboxylated polysaccharides covalently attached to a proteoglycan 
backbone; they confer a large negative fixed charge density to the tissue, which 
generates a swelling pressure acting to maintain hydration21- 23• 
2.2 Osteoarthritis 
Osteoarthritis (OA) is a chronic, non-inflammatory disease of the articular 
joints. As one of the leading causes of disability and lifestyle limitations in the 
United States, arthritis is estimated to cost the U.S. economy $128 billion 
annually; further, its prevalence (27 million people in the U.S.) makes it a crucial 
healthcare concern2• OA arises from the breakdown of articular cartilage; the 
degeneration is progressive, and can have complex etiology. Older persons are 
more likely to experience OA, since a . lifetime of wear can induce cartilage 
breakdown in joints. Some younger patients also experience OA, which can be 
hastened by trauma or other anatomic abnormalities that contribute to excessive 
joint loading or biomechanical instability20,24 • The breakdown of cartilage tissue at 
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articular joints compromises joint function and causes pain, swelling, impaired 
function (tenderness, instability, loss of motion), osteophytes and subchondral 
bone sclerosis. 
In osteoarthritis, cartilage's capacity to resist compressive loads decreases; 
the tissue becomes soft and swollen, due to increased water content. Other 
concurrent events include loss of GAGs, alterations in proteoglycans, and 
collagen and proteoglycan binding to hyaluronic acid2S-27• In particular, the lower 
GAG content in osteoarthritic tissue increases hydraulic permeability28• This 
change results in more of the applied load being borne by the collagen-
proteoglycan matrix, rather than interstitial water. Matrix damage ensues, with 
early damage occurring as collagen fibrillation in the superficial zone. As 
damage progresses, cartilage breakdown can cause substantial cartilage erosion 
and thinning, even down to the subchondral bone surface. 
There is no known cure for OA. Articular cartilage has a limited capacity 
to self-heal; therefore, rendering a diagnosis at a late stage is ineffective at 
reversing or preventing further cartilage degeneration. Currently, most 
treatments focus on reduction of pain and maintaining mobility56 • The most 
commonly prescribed treatments include NSAIDs, physical therapy, weight 
reduction and moderate exercise programs, steroid injections, 
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viscosupplementation, autograft transfer and microfracture, and if the damage 
and impairment is especially severe, partial or total joint arthroplasty2,29,3o. It is 
important to note that all of these treatments mitigate symptoms (chiefly, pain) 
without addressing the underlying cause of the disorder. Likewise, they are all 
applied at a relatively late stage of the disease, a time at which irreversible 
damage to a patient's articular cartilage has already occurred. 
2.3 Osteoarthritis diagnosis and monitoring via cartilage imaging 
As in most disorders, clinical care of OA would be enhanced by 
preventative or early disease stage therapeutic approaches. Unfortunately, 
clinicians are not equipped to diagnose OA in its early stages, largely because no 
sensitive, reliable imaging modality exists which detects the earliest changes in 
OA disease progression. Indeed, most diagnoses are made based on a clinical 
finding of pain and loss of motion, often with attendant medical imaging. 
Typically, plain x-rays are administered as a diagnostic tool-being readily 
available in most healthcare settings, and at low cost. However, since cartilage is 
mostly water and therefore radiopaque, articular cartilage appears as negative 
space and cannot be visualized directly in conventional x-ray images-nor can it 
in computed tomography (CT) images. Furthermore, plain x-rays provide a 2-
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dimensional projection image through a joint, which represents a substantial loss 
of valuable diagnostic data that might otherwise be available in 3-dimensions. 
Still, plain x-ray films are useful for evaluating joint space narrowing, or the 
approach of articulating bones (Figure 2.1). As cartilage degrades during OA, 
cartilage volume is lost and the articulating bones become visibly closer. 
Concurrent bony changes ( osteophytes, subchondral bone sclerosis, etc.) may 
also be evident. However, and inspirational to the work presented in this 
volume, is that these are late-stage features of the disease. Hence, plain 
radiography is limited in its usefulness. Detection of OA in its earlier stages, 
which requires (ideally, 3-dirnensional) scrutiny of the cartilage tissue itself, is 
necessary for effectively mitigating the disease process. Alternatively, magnetic 
resonance imaging (MRI) is used to probe soft tissues in joints, and is the 
standard-of-care for identifying soft tissue pathologies such as ligament or 
meniscal tears31- 34• While MRI is capable of viewing cartilage directly and is adept 
at morphological evaluation, it is less useful for identifying early-stage cartilage 
pathology. Currently, no clinically available imaging modality is capable of 
identifying osteoarthritis in its early stages. 
However, new opportunities exist with imaging methods that can 
measure changes in the biochemical content and biomechanical integrity of 
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articular cartilage before clinical symptoms and radiographic changes are 
evident. These may provide physicians an opportunity to diagnose and mitigate 
OA before irreversible changes to the cartilage transpire. 
2.3.1 Magnetic resonance imaging (MRI) 
Magnetic resonance imaging (MRI) of cartilage has been used in many 
clinical and research applications since the 1980's. Its ability to generate high-
quality images of all the joint structures (including bone, cartilage, menisci, 
synovium, and ligaments) has made MRI the current "gold standard" for OA 
imaging. Many studies have shown efficacy in determining cartilage thickness, 
volume, and surface topography using MRPS-41. Additionally, several MRI-based 
techniques (T2 mapping, Tlrho, and 23Na+ mapping) have been shown to reflect 
the GAG and collagen content of articular cartilage38A2-46• Quantitative analysis of 
GAG content is especially sought because GAG loss is an indicator of early-stage 
OA (Figure 2.2)47A8• The Delayed Gadolinium-Enhanced MRI of Cartilage 
( dGEMRIC) technique in particular can accurately differentiate between healthy 
and osteoarthritic cartilage both ex vivo and in vivo by assessing GAG contents37-
42,44,49- 52 
The GAGs in cartilage impart a negative fixed charge density to the tissue. 
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To maintain electroneutrality, each fixed negative charge is offset by a nearby 
counterion in the interstitial water; the result is that the total ion concentration 
inside cartilage is greater than the external solution. This ion imbalance produces 
an osmotic swelling pressure, known as the Donnan osmotic pressure, which 
serves to maintain cartilage hydration. Cartilage, then, closely reflects the theory 
proposed by F.G. Donnan53 in the 1920's when he described the influence of 
immobile charges on two-compartment systems with other freely mobile ions; 
the freely mobile ions partition according to the relationship, 
Equation 2.1 
where ct is the internal concentration of freely mobile cation, ci- is the internal 
concentration of freely mobile anion, c: and c;; are the concentrations of these 
ions in the external bathing solution, and Z is the valence of each ion. This 
relationship is referred to as Donnan equilibrium, and several prominent 
researchers in the field such as A. Maroudas have shown that partitioning of 
common ions (such as Na+ and Cl-) in cartilage follow Donnan equilibrium very 
closely54,55• 
To harness this property of cartilage for a clinical application, dGEMRIC 
uses chelated gadolinium (Gd-DTPA, net -2 charge) as a mobile anionic probe 
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that partitions throughout the ECM in inverse proportion to the negative fixed 
charge density established by the GAGs. Since the anionic Gd-DTP A is partially 
excluded from the cartilage ECM due to its negative fixed charge density, 
partitioning can be used as a indicator of local fixed charge density and thereby 
can indicate GAG content. In dGEMRIC, since imaging signal (spin-lattice 
relaxation time constant, known as Tl) varies indirectly with the concentration of 
Gd-DTP A, the mapped Tl directly indicates the concentration and spatial 
distribution of GAG throughout the cartilage ECM. However, as cartilage 
degenerates and hydraulic permeability of the ECM increases, the molecular 
mobility changes, affecting the relative timing of image acquisition for delayed 
uptake of Gd-DTP A after injection. This variability complicates standardization 
of clinical protocols and interferes with longitudinal intra- and inter-subject 
comparisons. Moreover, the use of dGEMRIC in elderly patients and diabetics is 
limited by the risk of renal toxicity associated with IV injection of Gd-DTPA56 • 
This is a particular concern as diabetes and OA are co-morbidities, often having 
strong association with advanced age and increased body weight. While MRI is 
the current "gold standard" for assessing articular cartilage health, there remain 
distinct disadvantages and barriers to widespread clinical use. High cost, the 
need for high field strength magnets to improve spatial resolution, long 
15 
acquisition times, the requirement for specialized coils to improve signal to noise 
ratio, the obligation for specialized software algorithms to segment articular 
cartilage and map relaxation times, and the lower accessibility of MRI scanners 
compared to other imaging equipment all contribute to the challenge of using 
MRI techniques for imaging cartilage. 
2.3.2 Contrast-enhanced computed tomography (CECT) 
Computed tomography (CT) is a developing technique for imaging 
cartilage. As with plain radiography, standard CT cannot be easily used to 
evaluate cartilage in vivo since cartilage does not attenuate x-rays very well. 
However, contrast-enhanced computed tomography (CECT) using an iodinated 
contrast agent injected intra-articularly has been used for decades in surgical 
planning to facilitate visualization of joint articular surfaces especially in the hip, 
shoulder, knee, elbow and foot57-61• Among its advantages over MRI techniques, 
CT is less expensive, more widely accessible, achieves higher spatial resolution 
(providing better identification of thin tissues like cartilage and also enabling 
higher quality image reconstruction at multiple viewing angles), shorter 
acquisition times (minimizing movement artifacts) without the need for special 
coils or high field strength magnets, can image both bone and cartilage 
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simultaneously with equal fidelity, is less affected by the presence of orthopedic 
implants, and avoids the risk of side effects from intravenous Gd-DTP A 
administration. Following a procedure analogous to dGEMRIC, several recent 
studies have used CECT to measure the concentration and spatial distribution of 
an anionic, iodinated contrast agent diffused through articular cartilage3A,6,B, ID,62-M. 
Since x-ray attenuation depends directly on the concentration of iodine 
partitioned throughout the ECM, the contrast-enhanced CT image indirectly 
reflects the GAG content of the cartilage ECM. 
Several studies in the last several years have focused on CECT imaging of 
cartilage. In 2006, Palmer et al. demonstrated the use of a commercially available 
anionic contrast agent, ioxaglate (trade name Hexabrix®), to partition into 
articular cartilage in inverse proportion to GAG content4. In their ex vivo rat 
model, the authors found good correlation between CECT attenuation (measured 
via micro computed tomography, 1-1CT) and tissue GAG content. They showed 
that 1-1CT attenuation using Ioxaglate was a good predictor of GAG content in 
progressively GAG-depleted tissue samples. Similarly, a 2010 study by Xie et al. 
showed another ex vivo rat model in which 1-1CT with ioxaglate successfully 
tracked the naturally occurring GAG changes in rats of different ages65• A similar 
study by the authors demonstrated the capacity of CECT to elucidate cartilage 
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morphological parameters (thickness, volume, and surface area)64• In addition to 
morphology and biochemistry, CECT has the potential to predict mechanical 
properties (and hence, performance during loading) of cartilage. In 2010, Bansal 
et al. used a mated bovine osteochondral plug model to show that CECT 
attenuation with iothalamate (trade name Cysto-Conray II®, another 
commercially available anionic contrast agent) correlated with both GAG content 
and equilibrium compressive modulus6• 
Ioxaglate and several other anionic contrast agents are approved for use in 
patients and have been used for applications such as CT angiography for over 30 
years66• Being anionic, the contrast is largely excluded from cartilage ECM, and 
high concentrations are required in order to get enough material into the tissue 
to yield meaningful signal. Additionally, the electrostatic repulsion through 
which CECT and dGEMRIC operate is a non-specific association and may be 
subject to other modulating influences. 
A 2010 study by Benders et al. investigated the impact of using CECT to 
image formalin-fixed bovine cartilage samples67• They compared similar bovine 
samples that were both fixed and unfixed, and found that on average fixed 
samples had a 14% lower CECT attenuation than unfixed samples. The authors 
reasonably postulated that this decreased contrast uptake could be due to the 
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protein and GAG crosslinking that results from formalin fixation, which forms a 
tighter ECM and could dramatically reduce pore size and hence permeability in 
cartilage tissue. Extending this result, it is reasonable to suspect that natural 
variations in pore size (due to collagen content and orientation, GAG content, 
hydration, etc.) also influence contrast uptake. Indeed, many have suggested that 
anionic contrast partitioning may be largely (and confoundingly) influenced by 
these other factors5,62,67• This is a relevant question for both CECT and dGEMRIC, 
as both are predicated upon partitioning of an anionic contrast agent. Therefore, 
CECT with anionic contrast agents may not be reproducible or consistent across 
multiple samples with drastically varying compositions. 
Concurrently, several groups have focused upon the CECT "mechanism 
of action" and its implications for reliable quantitative use. For instance, it is 
important to keep in mind that quantitative GAG measurements, as they are 
based on Donnan equilibrium, must be collected when the tissue has in fact 
achieved equilibrium with the bathing contrast solution. Silvast et al. have 
suggested that incomplete diffusion precludes the accurate representation of 
GAG content (especially with respect to its spatial distribution), and that more 
work needs to be done to determine how contrast diffusion and equilibrium in 
cartilage is influenced by all structural and compositional factors62,63• In one 
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experiment, they found that contrast diffusion in ex vivo bovine patellar cartilage 
doesn't reach equilibrium for ~30 hrs, and therefore eventual clinical applications 
of the technique are impractical. Additionally, a 2012 study by Salo et al. found 
that contrast agent uptake in cartilage was dependent on collagen content and 
diffusion direction as well as GAG content68• Still, a few more recent studies have 
shown that CECT measured prior to diffusion equilibrium effectively quantify 
GAG content or indicated cartilage degenerative state69- 71 • 
Given these challenges and the unmet need for a contrast agent designed 
specifically with cartilage in mind, the Grinstaff Group at Boston University 
developed a suite of cationic iodinated contrast agents. Under the overarching 
hypothesis that cationic iodinated contrast agents would be better for imaging 
cartilage, especially for quantifying GAG content, compared to similar anionic 
products. Namely a cationic contrast agent will be electrostatically attracted to 
anionic GAGs in cartilage, and therefore should provide sensitive imaging 
reflective of cartilage health (Figure 2.3). Indeed, several preliminary studies 
were conducted with promising results. A 2009 report by Joshi et al. presented 
the chemical synthesis of the cationic agents, and showed high uptake in rabbit 
articular cartilage12• Studies by Bansal et al. in 2010 and 2011 showed that 
compared to anionic agents, cationic agents are highly taken up in articular 
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cartilage and are more sensitive to GAG content, even when used at dramatically 
lower concentration6·7. 
2.4 Contemporary therapeutic interventions for osteoarthritis 
OA treatment strategies take a variety of forms. As discussed previously, 
many approaches simply seek to alleviate a patient's pain while others aspire to 
repair improper joint function. Relieving pain, in particular, is often the chief 
goal and is most readily addressed using small molecule therapies. To date, 1695 
clinical trials are underway related to OA72• Of these, 682 are investigating drugs 
including analgesics (narcotic and non-narcotic), anti-inflammatories, anti-
infectives, and psychotropics, among many others. Biologics are also being 
explored for OA therapy. 
Additionally, there are plentiful examples in the scientific literature of 
tissue engineering and biomaterials-based strategies for repairing OA tissue. 
Most of these develop scaffolds with or without cellular additives or biochemical 
factors to promote tissue healing, especially in focal cartilage defects73-83 . 
Although these strategies have been heralded with much excitement, none thus 
far are clinically utilized. Common complications include delamination and poor 
scaffold integration into native cartilage tissue84•85, poor control over cellular 
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phenotype and zonal tissue architecture86,87, sub-optimal mechanical 
performance86,8B-90, and healing based on fibrocartilage rather than true articular 
cartilage91 • 
One additional impedance in evaluating these treatments is the lack of a 
sensitive technique for tracking GAG content and cartilage structural changes 
over time in vivo. Rather, tissues from OA animal models are analyzed via 
destructive methods (such as histology), making longitudinal studies difficult. A 
sensitive imaging modality for determining cartilage properties in vivo could 
play an important role in the development of successful small molecule therapies 
and tissue engineering strategies, both of which are fields that have received 
much attention but relatively little success for OA applications in recent years. 
Likewise, another common therapeutic approach is viscosupplementation, 
which aims to reduce friction in joints containing degenerated cartilage. Since 
OA cartilage is often fibrillated (causing surface roughness)92,93, GAG-depleted 
(causing poor fluid pressurization)18, and the joint contains abnormal synovial 
fluid94-96, the injection of a lubricious solution into affected joints has been 
hypothesized to reduce pain and improve function in patients. Commercially 
available viscosupplements (for example, Synvisc-One®, Genzyme; Orthovisc®, 
DePuy Mitek; Euflexxa®, Ferring Pharmaceuticals) are used in clinic for 
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moderate to severe OA, especially in the knee. However, their efficacy is 
disputed97- 99• More recently, synthetic lubricious polymers have been developed 
and reported in the scientific literature which reduce cartilage coefficient of 
friction and were designed to maintain longer joint residence time100• 
All of the aforementioned therapeutic paradigms focus on symptomatic 
OA. However, treating OA in its very early (non-symptomatic) stages could 
potentially reduce the incidence of this painful, debilitating condition. Indeed, 
CECT of cartilage seeks to identify and monitor OA progression, and concurrent 
therapeutic efficacy, even from its very early stages. To date, however, no 
clinically available therapeutic strategy addresses OA at its early stages. 
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Figure 2.1: Full-thickness cartilage erosion in the medial compartment of an 
adult knee following a history of high-impact athletic participation (58 year 
old male) gives evidence of moderately severe OA. Radiographic changes 
were accompanied by pain, instability, and effusion. 
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Figure 2.2: Histological sections with Safranin-0 staining for GAGs. 
Normal cartilage (left) maintains an abundance of GAGs; early-stage 
osteoarthritic cartilage (right) exhibits GAG depletion, although no 
macroscopic evidence of damage is evident. Though histology is well suited 
for detecting these early changes, the technique is destructive. A non-
invasive technique for determining this GAG loss would have a high 
impact. 
Healthy cartilage (more GAG) 
II ~~ill'J JJiiFe 
Early-stage OA (less GAG) 
X-ray attenuation 
starts low in healthy 
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X-ray attenuation 
starts high in healthy 
cartilage and decreases 
as it degrades 
Figure 2.3: Schematic showing anionic and cationic contrast agent uptake in 
healthy and degenerated cartilage. CECT x-ray attenuation is dependent 
upon intra-tissue contrast agent, which is proportional to and can be used to 
quantify GAG content. 
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Chapter 3: A Cationic Contrast Agent for Computed Tomography is Highly 
Taken Up in Articular Cartilage and Reflects Glycosaminoglycan Content 
3.1 Introduction 
Diminishing glycosaminoglycan (GAG) content in articular cartilage is an 
early event in the progression of osteoarthritis (OA). Electrostatic attraction and 
repulsion between anionic GAGs and charged contrast agents can be harnessed 
to quantify changes in GAG content in cartilage tissue. In particular, contrast-
enhanced computed tomography (CECT) of cartilage is a developing technique 
for both clinical and research applications; to effectively quantify GAG content 
using this imaging modality, a contrast agent must diffuse into and partition 
within the extracellular matrix (ECM) in proportion to GAG content. A 
commercially available anionic iodinated contrast agent, ioxaglate, is commonly 
used for this purpose. Due to electrostatic repulsion, ioxaglate distributes in the 
ECM in inverse proportion to GAG content. Hence, much of the contrast is 
excluded from the tissue and high concentrations are needed to produce 
adequate signal. Accordingly, a novel cationic iodinated contrast agent was 
developed, being specifically designed with cartilage biochemical properties in 
mind12• The contrast agent, CA4+, which bears four positive charges, performs 
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mechanistically opposite to ioxaglate whereby CA4+ partitions in cartilage ECM 
in direct proportion to GAG content. Importantly, this electrostatic attraction 
produces high uptake of contrast agent by the cartilage tissue. In this study, the 
hypotheses were that 1) both cationic and anionic contrast agents will quickly 
diffuse into cartilage in a bovine osteochondral plug model, 2) CA4+ will be 
highly taken up in cartilage compared to ioxaglate, 3) uptake of both contrast 
agents will reflect GAG content, with CA4+ being efficacious at a lower 
concentration than required for ioxaglate, and 4) CA4+ will produce high quality 
images for morphological assessment even when used at low concentration. 
3.2 Materials and Methods 
3.2.1 Contrast agent diffusion in a bovine osteochondral plug model 
Bovine osteochondral plug specimens were harvested from five fresh 
adult cow knees (aged 1-2 years) procured from a local abbatoir (Bertolino Beef, 
Boston, MA). The bovine femurs were trimmed down to the most distal6 inches 
and the femoral shaft was clamped in a vice grip for steady positioning. A table-
mounted drill press (Delta Power Equipment Company, Anderson, SC) 
equipped with a 7 mm inner diameter diamond-tipped cylindrical cutter (Starlite 
Industries, Bryn Mawr, P A) was used under constant water irrigation to core 
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osteochondral plugs perpendicularly to the cartilage surface across the entire 
condylar surface. A schematic of the plug harvest is shown in Figure 3.1. 
Following harvest, each core was rinsed and stored at -20°C in a 400 mOsmol/kg 
saline solution with a preservative cocktail containing protease inhibitors, 
antibiotics, and antimycotics (5 mM EDTA, 5 mM Benzamidine HCl, Sigma-
Aldrich, St. Louis, MO; 1x Gibco® Antibiotic-Antimycotic, Life Technologies, 
Carlsbad, CA) until use in the experiments. 
In order to determine the time required for both cationic and anionic 
contrast agents to reach diffusion equilibrium in the plug model, a cationic 
contrast agent was synthesized as described in Appendix A12 and prepared at 16 
mg of Iodine per mL (mgl/mL) in deionized water (Barnstead™ NanoPure™, 
Thermo Fisher Scientific, Waltham, MA). The solution was adjusted to pH=7.4 
with sodium hydroxide. A solution of anionic ioxaglate was also prepared at 16 
mgl/mL (Hexabrix-320®, Mallinckrodt, Hazelwood, MO) as a dilution in 
deionized water. Both solutions contained the preservative cocktail as described 
above, and were adjusted to 400 mOsmol/kg (the average osmolality of synovial 
fluid) with sodium chloride96,101 • The molecular weight and estimated size of 
ioxaglate is 1,268.87 g/mol with a length of 26 A and width of 13 A; for CA4+ it is 
1,354.03 g/mol with length of 29 A and width of 18 A. 
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Ten bovine plugs (from five bovine knees) were thawed at room 
temperature for 4 hours prior to the experiment, and the plugs were scanned 
using micro computed tomography (flCT40, Scanco Medical AG, Briittisellen, 
Switzerland) at an isotropic voxel resolution of 36 flm, 70 kVp tube voltage, 113 
flA current and 300 ms integration time. Then, five plugs each were randomly 
assigned to and immersed in an excess (2 mL, approximately 20x the cartilage 
volume) of the prepared CA4+ or ioxaglate solutions. The plugs were 
periodically removed from their contrast baths, gently blotted with laboratory 
tissue, and imaged again. The total diffusion time was 20 hours. Contrast agent 
solutions and deionized water were also scanned with the same settings inside 
polypropylene tubes with similar dimensions to the osteochondral plugs. The CT 
images were converted to DICOM format and imported into analysis software 
(Analyze®, AnalyzeDirect, Overland Park, KS), which enabled semi-automatic 
contour-based segmentation of the cartilage from the subchondral bone. The 
mean x-ray linear attenuation coefficient of each cartilage plug was converted to 
Hounsfield Units (HU) by normalizing to that of the deionized water. For each 
plug, CECT attenuation was corrected by subtracting the attenuation of the non-
contrast (baseline) scan, then normalizing by contrast agent solution attenuation. 
This value is equivalent to the partition coefficient, K, which expresses the ratio 
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between the concentrations of contrast agent inside the cartilage tissue at 
equilibrium compared to the solution concentration in the surrounding bath. The 
partition coefficient was plotted as a function of time, and was represented with 
a nonlinear mixed effects model of the functional form: 
( -time) C ECT = K E * 1 - e-T- Equation 3.14,102 
where KE is the (maximum) partition coefficient at equilibrium and the time 
constant rr is the time required to reach 63.2% of the maximum (MATLAB®, 
MathWorks, Natick, MA). For each contrast agent, the time constant owing to 
fixed effects was reported as a representative equilibration time constant. A 
Student's t-test was used to compare KE and rr between CA4+ and ioxaglate (SPSS 
vl7.0, IBM, Armonk, NY). 
3.2.2 Glycosaminoglycan quantification using ionic contrast agents 
In a second experiment, ten bovine plugs (from five knees) were used to 
examine the capability of both anionic and cationic contrast agents to quantify 
GAG content. Solutions of ioxaglate (16 mgl/mL) and CA4+ (8 mgl/mL) were 
prepared as previously described (pH balanced, osmolality adjusted, 
preservative cocktail added). All ten bovine plugs were immersed in the 
ioxaglate solution and incubated at room temperature for 24 hours. After the 
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incubation, the plugs were scanned using flCT with the same parameters as 
described above. Subsequently, each plug was immersed in a large bath (10 mL, 
100x the cartilage volume) of saline with the preservative cocktail to rinse out the 
ioxaglate. After 24 hours of rinsing, the plugs were imaged again to confirm the 
removal of ioxaglate. Then, all ten plugs were immersed in the CA4+ solution for 
24 hours at room temperature, scanned, and again immersed in copious saline 
for 24 hours to remove the CA4+. Following the final rinsing, each plug was 
gently blotted dry with laboratory tissue, sharply transected from the 
subchondral bone using a #11 blade scalpel, and weighed. Each specimen was 
then lyophilized to remove the tissue water component, re-weighed, and the 
total water content was calculated as a percentage of tissue mass. In order to 
determine the GAG content of each plug, the colorimetric 1,9-dimethylrnethylene 
blue assay was performed (Appendix B), and GAG content was reported as a 
percentage of tissue mass. 
The CECT data was analyzed as described above, where the CECT 
attenuation was corrected by subtracting the attenuation of the non-contrast 
(baseline) scan, then normalizing by contrast agent solution attenuation. For both 
contrast agents, univariate linear regression was performed to evaluate the 
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relationship between K and GAG content as well asK and water content (SPSS 
v17.0). 
3.2.3 Cartilage imaging in an intact, ex vivo rabbit knee joint 
As a third comparison between CA4+ and ioxaglate cartilage imaging, the 
contrast agents were diffused into the trochlear groove cartilage in ex vivo rabbit 
knee joints. Two frozen contralateral rabbit knees were purchased (Pel-Freez 
Biologics, Rogers, AR), defrosted at 4oC overnight, and trimmed of most of the 
soft tissue while leaving the joint capsule intact. Then, one joint was injected via 
25-gauge needle with 5 mL of 12 mgl/mL CA4+ solution while one knee was 
similarly injected with 12 mgl/mL of ioxaglate solution. The joints were allowed 
to rest at room temperature for four hours and then were scanned with !J.CT 
using the same parameters as in the plug studies. Following scanning, the joint 
injected with ioxaglate was lavaged with saline, manually compressed to remove 
the lavage fluid, and injected with 4 mL of ioxaglate at 80 mgl/mL. After four 
additional hours of room temperature incubation, the joint was scanned again 
with f1-CT. CECT images were visually compared for cartilage morphology. 
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3.3 Results 
3.3.1 Contrast agent diffusion in a bovine osteochondral plug model 
For both ioxaglate and CA4+ in the bovine osteochondral plug model, 
diffusion equilibrium was reached well before 20 hours (Figure 3.3). The time 
constant, rr, was 1.12 ± 0.20 (Mean± StDev) hours for ioxaglate and 1.74 ± 0.12 
hours for CA4+, which were statistically different (p = 0.02). For CA4+, the mean 
partition coefficient K = 2.26 ± 0.28 and for ioxaglate the mean K = 0.58 ± 0.09, 
which were also statistically different (p < 0.0001). 
3.3.2 Glycosaminoglycan quantification using ionic contrast agents 
For CA4+, the partition coefficient (K) was between 2 and 3 and it strongly 
correlated with GAG content (R2 = 0.83, p < 0.001). For ioxaglate, K ~ 0.5 and its 
correlation with GAG content was not statistically significant (R2 = 0.20, p = 0.19) 
(Figure 3.4). Partition coefficient did not statistically correlate with water content 
for either CA4+ or ioxaglate (data not shown). 
3.3.3 Cartilage imaging in an intact, ex vivo rabbit knee joint 
In the color map images showing intact ex vivo rabbit knees injected with 
either CA4+ or ioxaglate at 12 mgl/mL (Figure 3.5), only CA4+ produced clear 
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attenuation differentiation between soft tissues, cartilage, and the underlying 
subchondral bone. This concentration of ioxaglate did not yield sufficient 
cartilage signal to distinguish it from the surrounding soft tissue, but the second 
injection of ioxaglate at 80 mg 1/mL did allow the cartilage to be more clearly 
seen as a low-attenuation space between the highly attenuating ioxaglate pooled 
in the joint space and the underlying subchondral bone. 
3.4 Discussion 
In the contrast diffusion experiment, both ioxaglate and CA4+ were taken 
up in articular cartilage. Being anionic, ioxaglate was partially excluded from the 
cartilage with an average partition coefficient less than one (::::0.58). CA4+, on the 
other hand, had an average partition coefficient greater than one (::::2.26) owing to 
the electrostatic attraction between CA4+ and GAG. Hence, by virtue of its 
cationic charge, CA4+ enables more contrast agent to accumulate inside the 
cartilage tissue per applied concentration compared to an anionic contrast agent. 
In a clinical scenario, this increased uptake could be useful for reducing the 
required contrast dose applied to articular joints while still producing sufficient 
contrast-to-noise ratios needed for obtaining high quality images. 
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Both ioxaglate and CA4+ showed a diffusion time constant ('I) of between 
1-2 hours in this osteochondral plug model. Since diffusion equilibrium can 
safely be considered to be completed by 4-5 time constants103, this data suggests 
that contrast agent diffusion should be permitted for at least 8-10 hours to ensure 
that equilibrium has been reached. The difference in 'I for ioxaglate and CA4+ is 
small ·but statistically significant, and may be due to the increased interaction 
between anionic GAG and cationic terminal groups on the CA4+ molecule, 
which could slow diffusion. The nature of the interaction between cationic CA4+ 
and anionic GAG content warrants further investigation as it will have 
substantial implications for the diffusion of CA4+ through cartilage, which 
subsequently will influence its utility as a molecular probe for GAG content. 
Additionally, it is important to note that this bovine osteochondral plug model 
does not perfectly recapitulate the diffusion of contrast agents in vivo, since in 
this model contrast agent diffusion is permitted through both the articular 
surface (axial diffusion) and through the cut specimen edges (radial diffusion) 
(Figure 3.6). Because of the exposed edges, diffusion can occur through a larger 
(::::2x) surface area per tissue volume in this model geometry, which very likely 
speeds diffusion (decreases 'I). In addition, the cut edges of the plugs do not 
represent a physiologic surface, and diffusion may occur at different rates since 
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there are significant tissue differences at play between an axial and a radial 
diffusion direction104. This limitation should be noted, especially when contrast 
agent studies contain a diffusion kinetics component. 
In the GAG quantification experiment, the correlation between GAG 
content and partition coefficient was statistically significant and strong for CA4+ 
but not for ioxaglate. Previous studies have reported statistically significant 
results for ioxaglate, but these studies used a much higher (5-12x) concentration3-
6,s,to,62. This experiment shows that CA4+ is capable of producing meaningful 
correlations with GAG even when the applied dose is low-indeed, in this case 
CA4+ was used at 50% lower iodine concentration than ioxaglate. Much higher 
concentrations of ioxaglate must be required to produce significant correlations. 
This result is encouraging because it gives evidence that a low applied dose of 
CA4+ could yield reliable quantitative information regarding cartilage GAG 
content. However, this experiment was conducted in an idealized model which 
neglects some important features and concerns of cartilage imaging in intact 
and/or in vivo joints. As mentioned above, diffusion occurred across both 
physiologic and non-physiologic surfaces. These experiments were also 
conducted at room temperature (22oC) whereas the average knee joint 
temperature is 34°C105,106• Also, the cartilage was bathed in contrast agent 
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solutions with constant concentrations, which is not likely in vivo. For a contrast 
agent administered via intra-articular injection, efflux from the joint space would 
occur concurrently with diffusion into the cartilage, which changes the diffusion 
boundary conditions with time. Further, human cartilage may behave differently 
than bovine cartilage using CECT, so it is important to explore diffusion and 
uptake in human specimens as a step towards developing a diagnostic tool. 
In the rabbit joint imaging experiment, CA4+ at a relatively low 
concentration yielded quality morphological images of the trochlear groove 
cartilage. Ioxaglate CECT required a much higher concentration in order to 
provide sufficient image contrast. These results suggest an advantage of cationic 
contrast agents over anionic agents, in that they can provide quality images at a 
low applied dose. In clinic, this could reduce the risk of any adverse side effects. 
Although ioxaglate is generally well-tolerated, some patients can experience 
side-effects that range from unpleasant to life-threatening107- 110• The toxicity and 
pharmacokinetic profile of the CA4+ has not yet been fully studied, but will be an 
important future step for evaluating the overall efficacy and biocompatibility of 
the contrast agent. 
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Figure 3.1: Osteochondral plugs (7 mm diameter) were cored from the 
surfaces of bovine condyles. 
~ ~ 
H,N~J:h~n~R,::NH, H ,):::, O H ~ ~' 
~ ~x x~ ~ HO~N ~ N NMe 
(A) H3N~~ 0 0 ~ NH3 (B) 0 I 0 I 0~ 
Figure 3.2: Chemical structures of the cationic contrast agent, CA4+ (A) and 
the commercially available anionic contrast agent, ioxaglate (B). 
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Figure 3.3: Mixed effects models of CA4+ and ioxaglate diffusion in n=S 
osteochondral plugs each over 20 hours reveals diffusion time constants of 
1.74 and 1.12 hours, respectively, which are statistically different (p = 0.02). 
The black curves signify model fixed effects only, which is representative of 
each population as a whole, and the colored curves represent diffusion in 
individual plugs (fixed and random effects).116 
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Figure 3.5: Ex vivo rabbit trochlear groove cartilage enhanced with CA4+ 
(left), and the contralateral joint enhanced with ioxaglate at two different 
concentrations (middle and right). CA4+ provides good image contrast 
between the subchondral bone, cartilage, and surrounding joint space. 
Ioxaglate provides sufficient contrast only at high concentration (right), in 
which the cartilage appears as a lower attenuating space between the 
subchondral bone and highly attenuating ioxaglate solution in the joint 
space.116 
(A) 
Figure 3.6: Schematic showing contrast diffusion in a bovine osteochondral 
plugs model. In (A), contrast can diffuse into the cartilage through the 
articular surface and the radial edges. In (B), radial contrast agent diffusion 
is restricted, which is more close to the boundary conditions in vivo. 
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Chapter 4: In Vivo and Ex Vivo Contrast-enhanced Computed Tomography in 
a Rabbit Model of Early Osteoarthritis 
4.1 Introduction 
Contrast-enhanced computed tomography (CECT) of cartilage is an 
emerging technique for evaluating cartilage biochemical and biomechanical 
properties. Most studies employ ex vivo models which benefit from controlled 
equilibration between cartilage explants and the surrounding contrast reservoir. 
In vivo, however, the diffusion kinetics of the contrast agent into the cartilage 
occurs concurrently with the extravasation of the contrast agent out of the 
synovial joint, thereby complicating quantitative measurements. Both cationic 
and anionic contrast agents for CECT have been shown to indicate biochemical 
and biomechanical properties of cartilage in these controlled ex vivo 
environments, but in the current study the diffusion kinetics of cationic and 
anionic contrast agents (CA4+ and ioxaglate, respectively) are investigated in an 
in vivo rabbit model and compare the imaging results to those acquired from ex 
vivo imaging studies at diffusion equilibrium. 
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4.2 Materials and Methods 
All animal procedures were approved by the institutional animal care and 
use committee at Beth Israel Deaconess Medical Center. Five male New Zealand 
White rabbits (Millbrook Breeding Labs, Amherst, MA) were anesthetized by 
intramuscular injection of ketamine/xylazine and received isoflurane for the 
duration of each injection and imaging experiment. Under anesthesia, one 
randomly selected knee per rabbit was injected intra-articularly with IL-1~ (75 
ng/joint in 500 ~L sterile PBS) via the suprapatellar recess to induce cartilage 
degradation in the trochlear cartilage111- 113• The contralateral joint served as an 
intra-rabbit control. After injection, the animals were permitted normal cage 
activity for one week. Subsequently, each rabbit was anesthetized again and both 
knees were injected intra-articularly with 3 mL of sterile 80 mgi/mL ioxaglate 
solution (Hexabrix-320®, Mallinckrodt, Hazelwood, MO) mixed with 0.3 mL of 
epinephrine (1:1000). Epinephrine induces vasoconstriction to reduce transport 
of the contrast agent out of the synovial joint114,115• Ten consecutive pQCT scans 
(XCT Research SA+, Stratec Medizintechnik, Pforzheim, Germany) at 100 ~m in-
plane resolution and slice thickness, 50 kVp tube voltage, and 300 ~A current 
were obtained of the same axial slice to monitor the diffusion of the contrast 
agent into the femoral groove cartilage over 100 minutes. After 2-3 days, each 
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rabbit was anesthetized again and both knees were injected intra-articularly with 
3 mL of 12 mgi/mL CA4+ mixed with 0.3 mL of epinephrine. Time course scans 
were obtained as with ioxaglate. The rabbits were then euthanatized and each 
femur was excised, stripped of soft tissue, and immersed in saline with a 
preservative cocktail (5 mM EDTA, 5 mM Benzamidine HCl, Sigma-Aldrich, St. 
Louis, MO; lx Gibco® Antibiotic-Antimycotic, Life Technologies, Carlsbad, CA) 
for 24 hours at room temperature to remove residual contrast agent. Each femur 
was then fully immersed in 80 mgl/mL ioxaglate solution for 24 hours and 
scanned using micro computed tomography (~CT40, Scanco Medical, AG, 
Bri.ittisellen, Switzerland) at an isotropic voxel resolution of 36 ~m, 70 kVp tube 
voltage, 113 ~A current, and 300 ms integration time. For the in vivo pQCT 
images, at each time point, the cartilage and joint space fluid were manually 
segmented. The mean CECT attenuation in Hounsfield Units (HU) was obtained 
by averaging all pixels in the segmented cartilage or joint space, and CECT 
attenuation was plotted as a function of diffusion time. A nonlinear mixed effects 
model of the functional form A*(l-exp (-t/'r)) was fit to the pQCT diffusion-in 
data, where A is the maximum CECT attenuation at steady-state, and 'r is the 
diffusion time constant representing the time required to reach 63.2% of the 
maximum attenuation (MATLAB®, MathWorks, Natick, MA). A Student's t-test 
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was used to compare the diffusion time constants for ioxaglate and CA4+ (SPSS 
v17.0, IBM, Armonk, NY). For the ex vivo ~CT images, a region of interest was 
selected at the same location as was imaged during in vivo pQCT imaging. The 
equilibrium ~CT images were segmented, attenuation was also expressed in HU, 
and compared to the steady-state asymptotic values (A) from pQCT imaging. To 
do so, for both data sets, the cartilage CECT attenuation in each joint was 
normalized to the attenuation of the control joint and a paired samples t-test was 
used to compare CECT attenuation between control and degraded knees. 
Additionally, univariate linear regression was used to express in vivo steady-state 
pQCT attenuation as a function of equilibrium ex vivo ~CT attenuation for both 
CA4+ and ioxaglate-enhanced joints. pQCT data was lost due to technical error 
during one imaging session (Rabbit #2, degraded joint, ioxaglate imaging). 
4.3 Results 
During in vivo diffusion, ioxaglate was taken up into the control trochlear 
cartilage while also being cleared from the synovial space (as indicated by 
increasing and decreasing CT attenuations, respectively, Figure 4.1A). 
Approximately 20 minutes after injection, ioxaglate diffusion achieved a steady-
state in the trochlear cartilage ('r = 6.5 minutes from the fixed effects model)116• 
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Similarly, CA4+ was taken up in the control cartilage while also being cleared 
from the joint space (Figure 4.1B) and diffusion reached steady-state 
approximately 40 minutes after injection('[= 13.8 minutes from the fixed effects 
model), which was statistically different than ioxaglate (p = 0.04). Diffusion 
trajectories were similar for degraded knees (Figure 4.2), with steady-state being 
reached around 27 minutes for both contrast agents. For CA4+, the contrast-to-
noise (CNR) ratio improved with time while for ioxaglate, distinguishing 
between cartilage and surrounding joint space became more difficult (Figure 4.3). 
For both the ex vivo ~CT and in vivo pQCT imaging, ioxaglate revealed 
statistically significant differences between control and degraded joints (p = 0.019 
and p = 0.018 respectively, Figure 4.4) with degraded joints having higher 
ioxaglate uptake than control joints117• CA4+ did not reveal statistically 
significant differences in either case (Figure 4.5). However, in vivo steady-state 
attenuation positively correlated with ex vivo equilibrium attenuation for both 
CA4+ and ioxaglate (R2 = 0.49, p = 0.024 and R2 = 0.57, p = 0.019 respectively, 
Figure 4.6). 
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4.4 Discussion 
In vivo, the diffusion profiles for ioxaglate highlight a characteristic 
challenge with the use of anionic contrast agents for cartilage imaging. Since 
ioxaglate is partially excluded from cartilage, high concentrations are needed and 
the tissue appears as a low-attenuating space in the CT image. Over time, as the 
higher-attenuating ioxaglate diffuses out of the joint space, the CT attenuations 
of cartilage and the surrounding joint space converge, impairing the ability to 
differentiate the boundary. With CA4+, on the other hand, a low concentration 
(6.7x lower than ioxaglate) is highly taken up into the tissue (attenuation 
increases) while CA4+ diffuses out of the joint space, which results in clear 
distinction between cartilage, surrounding joint space, and bone. This is 
advantageous from a segmentation standpoint, and highlights the improved 
contrast-to-noise over longer imaging windows provided by a cationic contrast 
agent, like CA4+, with an affinity to GAGs in cartilage. 
This study demonstrates that that in vivo steady-state CECT attenuation 
reflects ex vivo CECT attenuation measured at diffusion equilibrium using both 
ioxaglate and CA4+. This finding is important for translating CECT to in vivo 
models. Namely, most CECT studies are conducted ex vivo at diffusion 
equilibrium, despite the fact that true diffusion equilibrium is unlikely to be 
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reached in vivo given considerations such as solute diffusivity, tissue thickness, 
and concurrent contrast agent efflux from the joint space. Despite these 
challenges, herein in vivo CECT measurements were representative of ex vivo 
equilibrium measurements and could potentially be used to predict them. Still, 
the moderate correlations between the two leave room for improvement and 
could be the result of several factors. In particular, the in vivo steady-state 
attenuations may not represent true diffusion equilibrium, and non-equilibrium 
contrast agent partitioning is particularly likely to be influenced by other factors 
than the tissue's fixed charge density, which equilibrium measurements seek to 
measure. This issue should be more thoroughly explored in vivo both in small 
and large animal models, the latter of which are even less likely to approach true 
diffusion equilibrium in vivo due, mainly, to prohibitive tissue thickness. 
Comparing control and degraded limbs using both in vivo steady-state 
pQCT and ex vivo equilibrium J.lCT in this experiment revealed that while 
ioxaglate showed a consistent attenuation difference between control and 
degraded joints, as would be expected, CA4+ did not show a consistent 
difference. This could be due to several factors, including the possibility that the 
IL-l~ injection did not cause consistent GAG depletion in the joints, and that the 
consistency seen with ioxaglate is due to chance in a small sample size (n=S) 
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rather than truly reflecting differences in GAG content. Alternatively, it is also 
possible that CA4+ poorly (though consistently) reflected real GAG differences 
both in vivo and ex vivo. The cause of this result would be uncertain, particularly 
for the ex vivo equilibrium !J-CT, since CA4+ has been shown to strongly reflect 
GAG content in other models6,13) 4. If the latter is the case, it is possible that an 
unexplored covariable also strongly influences CA4+ partitioning in this model, 
reducing the correspondence between contrast partitioning and GAG content. 
For instance, if IL-l~ treatment increased tissue permeability independent of 
GAG content alterations, CA4+ partitioning in degraded limbs might be 
somewhat higher than the joint's GAG content would predict. This potentiality 
may be an important challenge for using cationic contrast agents in general. For 
anionic contrast agents, multiple changes associated with cartilage degeneration 
(GAG loss, increased tissue permeability, and increased water content) tend to 
encourage greater contrast agent uptake both prior to and at diffusion 
equilibrium. For CA4+, however, these variables may act in opposite directions 
(e.g. GAG loss produces less contrast uptake while increased tissue permeability 
produces more). However, other factors associated with OA (such as collagen 
cross-linking) can have precisely the opposite effect with respect to ioxaglate and 
CA4+ partitioning. For instance, Benders et al. reported that formalin-fixed 
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cartilage tissue, a model for collagen crosslinking like that seen in OA, produced 
lower ioxaglate uptake (whereas concomitant GAG depletion in OA would be 
expected to produce more)67• In sum, in future studies it is critically important to 
evaluate multiple factors that influence contrast agent partitioning both prior to 
and at diffusion equilibrium. 
Although this study yielded some statistically significant results, there are 
several additional limitations as well as prudent experiments to be performed. 
First, this study had a very small sample size. Another limitation is the inability 
of the pQCT scanner to capture sufficient images to create volumetric 
reconstructions within a short timeframe. Also, different cartilage surfaces within 
a joint will vary in thickness and extracellular matrix component proportions, 
which may also affect contrast uptake and diffusion kinetics even within a given 
joint. Additionally, this study lacks external validation of the IL-lj3 degradations, 
in that their effect on the joint cartilage was not independently determined via 
any other method besides CECT imaging. Finally, additional safety and 
pharmacokinetics studies must be performed prior to any future use in 
preclinical animal trials or human clinical care. 
In this study, the feasibly of using CECT to detect cartilage degradation in 
a small in vivo model was explored. Since early changes in cartilage structure and 
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biochemical makeup occur well before macroscopic damage is evident, a 
sensitive method for detecting these changes in vivo could provide an important 
tool for diagnosing early OA, and provide an opportunity to intervene before 
irreversible changes to the cartilage become manifest. Additionally, small animal 
models for OA are an important tool in therapeutic research; the development of 
an imaging technique to longitudinally monitor animal study subjects could be a 
windfall for OA research efforts. 
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Figure 4.1: Nonlinear mixed-effects models for contrast agent diffusion into 
control rabbit trochlear cartilage following ioxaglate (A) and CA4+ (B) 
injection. Reported model parameters are for fixed effects only (dashed 
black line). Dashed colored lines represent attenuation in the joint space, 
and the dashed gray line represents the attenuation of the injected 
solution.116 
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Figure 4.4: CECT attenuations for rabbit trochlear cartilage enhanced with 
ioxaglate measured at diffusion equilibrium ex vivo (A) and at steady-state 
in vivo (B). pQCT data was lost due to technical error during one imaging 
session (Rabbit #2, degraded joint). Both imaging analyses revealed 
statistically different differences in contrast partitioning between control 
and degraded joints (p-values for the differences shown).117 
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Figure 4.5: CECT attenuations for rabbit trochlear cartilage enhanced with 
CA4+ measured at diffusion equilibrium ex vivo (A) and at steady-state in 
vivo (B). Neither imaging analysis revealed statistically different 
differences in contrast partitioning between control and degraded joints. 
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Chapter 5: Interaction Between Cationic Contrast Agents and 
Glycosaminoglycans in Articular Cartilage: Measurement of Diffusion and 
Equilibrium Partitioning 
5.1 Introduction 
Since articular cartilage is avascular, the diffusion of small molecules across the 
tissue's thickness is critically important for cartilage metabolism and subsequent 
proper functioning. Many reports of solute diffusion in articular cartilage6s,ns-126 
intervertebral disk127-129, temporomandibular joint13D-132, growth plate133 have 
characterized the landscape for solute diffusivities and equilibrium partition 
coefficients for solutes of varying properties (molecular weight, Stokes radii, 
charge, binding moieties) as well as different tissue properties (extracellular 
matrix depleted or cross-linked, tissue under compression, osteoarthritic, etc.). 
These studies have implications for medical applications that seek to 
purposefully diffuse a small molecule or protein into cartilage, especially m 
regards to osteoarthritis (OA) therapies and diagnostic techniques. In particular, 
the latter objective has been widely investigated in the last several years as 
multiple research groups are developing contrast agent-enhanced imaging 
techniques for identifying OA and quantifying disease state4•6·8•10·3BA2. Most of 
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these reports utilize an anionic contrast agent (gadopentetate, iothalamate, 
ioxaglate, etc.) partitioned into cartilage at diffusion equilibrium, which acts as a 
mobile ionic probe for quantification of glycosarninoglycan (GAG) content in 
cartilage. GAG is an anionic polysaccharide prolific in articular cartilage (2-7% by 
wet weight), and its function is to retain water inside the tissue extracellular 
matrix (ECM). GAG is critical to proper tissue hydration, and the water fraction 
in cartilage (65-85% of wet mass) primarily bears the compressive loading 
experienced by the tissue18--20• In many cases, GAG content is lost at an early stage 
of OA, which has the effect of transmitting more of the compressive loading to 
collagen fibrils that incur damage from overloading. This in turn produces 
cartilage that is soft, has high hydraulic permeability, and shows signs of 
macroscopic structural damage (fibrillation, thinning, and lesions). Imaging 
techniques that quantify GAG content minimally invasively could be a valuable 
tool for physicians seeking to diagnose OA in its early stages, as well as to 
monitor the effect of disease-modifying therapies. More recently, a quantitative 
imaging strategy has emerged for cartilage which utilizes cationic, rather than 
anionic, contrast agents. These cationic agents have shown their capability, even 
improved over anionic agents, to specifically and sensitively quantify GAG 
content7,13 as well as equilibrium compressive modulus and coefficients of 
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friction14 in articular cartilage. 
Previous cationic contrast-enhanced computed tomography (CECT) 
imaging data shows high partition coefficients (the ratio between intra-tissue and 
bath concentrations) for cationic agents (partition coefficient K > 1). The 
mechanism for this high contrast uptake could be purely electrostatic (i.e. high 
concentrations of mobile cations evolve in the tissue due to the anionic fixed 
charge density contributed by immobilized GAGs) or a stronger interaction 
(more akin to receptor binding) could be present between the cationic agent and 
moieties inside the cartilage ECM. If the latter occurs, determining a binding 
constant is an important step for characterizing the interaction and for further 
developing the quantitative CECT technique. Receptor-ligand binding studies 
are very commonly conducted by incubating a receptor with a wide range of 
ligand concentrations to determine a dissociation constant, Kd, which is an 
indicator of the binding strength between the receptor-ligand pair134-136• Herein, 
this technique will be used to evaluate the binding affinity between cationic 
contrast agents (CA2+ and CA4+, bearing +2 and +4 charges, respectively) and 
bovine cartilage ECM. Additionally, small cations in cartilage are also affected by 
electrostatic attraction to anionic GAGs, which could also explain the high 
partitioning of cationic contrast agents. The degree to which pure electrostatics 
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E 
(Donnan equilibrium theory) explains cationic contrast agent uptake will be 
explored. 
Prior studies of solute diffusion in cartilage highlight an alternative 
method for elucidating both the binding constant between a solute and cartilage 
while also determining the diffusivity of the solute through the tissue103,l37-14o. 
Both parameters are important for characterizing solute transport through 
cartilage. In these experiments, labelled solute is diffused through a thin cartilage 
specimen, and the evolved downstream solute is measured over time and 
converted via Fick' s laws of diffusion into an estimated diffusivity (D). The 
determined diffusivity is a measure of a solute transport at diffusion steady-
state, which is impacted by a number of factors including solute size, charge, 
cartilage hydration, GAG content, strain, temperature, osmolality, pH, and 
electric field67·11B-120·141-147. Additionally, the initial appearance of downstream 
solute yields information about potential binding interactions between solute 
and cartilage ECM. That is, molecules that display a substantial time lag in their 
penetration through a cartilage specimen are likely to be strongly interacting 
with the ECM. Multiple studies have utilized this method to evaluate solutes 
which bind cartilage ECM139•140 and those that do not103. 
In these experiments, the equilibrium partitioning (K) and diffusivity (D) 
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of cationic contrast agents in articular cartilage were evaluated, with special 
attention paid to indicators of binding interactions and the implications of K and 
D for CECT cartilage imaging. 
5.2 Materials and Methods 
5.2.1 Equilibrium partitioning of anionic and cationic contrast agents in 
cartilage 
The cationic contrast agents CA2+ and CA4+ were each prepared as six 
serial dilutions in deionized water containing 2, 4, 8, 16, 32, and 64 mgl/mL. Six 
serial dilutions of ioxaglate were prepared (Hexabrix-320®, Mallinckrodt, 
Hazelwood, MO) at the same iodine concentrations. All dilutions contained a 
preservative cocktail of protease inhibitors, antibiotics, and antimycotics to 
prevent tissue degradation over the course of the experiment (5 mM EDTA, 5 
mM Benzamidine HCl, Sigma-Aldrich, St. Louis, MO; lx Gibco® Antibiotic-
Antimycotic, Life Technologies, Carlsbad, CA). The pH of each solution was 
adjusted to pH 7.4 with sodium hydroxide, and sodium chloride was added to 
each dilution to achieve a solution iso-osmolar to synovial fluid (400 
mOsmol/kg). Nine bovine osteochondral plugs (7 mm diameter) were harvested 
from one bovine femoral condyle to obtain samples with a narrow variation in 
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GAG content. All nine samples were imaged with f1CT prior to contrast agent 
immersions (baseline scan). Three plugs (n=3) were randomly chosen for CA4+ 
immersions, and each was immersed in a large reservoir (4 mL) of 2 mgl/mL 
CA4+ for 24 hours and then imaged. Following imaging, the plugs were 
immersed in the next dilution in order of concentration ( 4 mgl/mL CA4+) for 24 
hours and then imaged similarly. This protocol of serial immersions was 
followed repeatedly to collect CECT imaging data for CA4+ at all six 
concentrations. The remaining six plugs were assigned to CA2+ (n=3) or 
ioxaglate (n=3) immersions, and an identical protocol was followed for each 
contrast agent. The contrast agent solutions were also scanned in a similar 
geometry as the plugs in order to produce a standard conversion curve between 
contrast agent concentration (mgl/mL) and CT attenuation (Hounsfield Units). 
After plug immersion and scanning for the highest concentrations (64 mgl/mL), 
all nine plugs were washed in copious saline for 24 hours and prepared for 
DMMB assay. Briefly, the cartilage was removed from the subchondral bone, 
weighed, and lyophilized to determine wet and dry cartilage masses. Each 
cartilage specimen was digested in papain buffer and the GAG content was 
assessed using the DMMB assay (Appendix B). 
During f1CT imaging, sequential axial images of the cartilage and 
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underlying subchondral bone were acquired using a micro computed 
tomographic imaging system (~-tCT40, Scanco Medical AG, Briittisellen, 
Switzerland) at an isotropic voxel resolution of 36 ~-tm, 70 kVp tube voltage, 113 
~-tA current and 300 ms integration time. The CT data sets were imported into 
image processing software (Analyze®, AnalyzeDirect, Overland Park, KS) and 
the cartilage was segmented using a semi-automatic contour based segmentation 
algorithm. The mean cartilage x-ray attenuation values using the Hounsfield 
Scale were obtained by averaging attenuation values for all cartilage tissue over 
the entire segmented volume. Then, the non-contrast (baseline) attenuation was 
subtracted from all contrast immersion attenuations, and the standard curve was 
used to convert CECT attenuation to contrast concentration inside the cartilage 
tissue. Linear regression analysis was used to express the intra-tissue contrast 
concentration as a linear function of the contrast reservoir concentration for 
plugs immersed in ioxaglate and CA2+. For CA4+, a modified Langmuir 
isotherm was fit to the data to illustrate the nonlinear relationship between 
reservoir concentration and intra-tissue concentration (MATLAB®, MathWorks, 
Natick, MA). This model allowed an ECso value to be calculated. 
In order to determine if the cationic contrast agents partitioned in cartilage 
according to the predications of Donnan equilibrium theory, a previously 
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published method was implemented in which the partition coefficient of contrast 
agent, KCA2+ or KcM+, was plotted as a function of the predicted sodium ion 
partition coefficient, I<Na+. The partition coefficients for CA2+ and CA4+ were 
calculated as the ratio between the intra-tissue concentration at equilibrium and 
the bath concentration. The partition coefficient for N a+ was calculated using the 
law of electroneutrality and Donnan equilibrium theory using custom MATLAB 
code. That is, Donnan equilibrium requires that53: 
Equation 5.1 
Where CcA is the intra-tissue concentration of contrast agent, CcA is the bath 
contrast concentration, CNa+ is the intra-tissue sodium concentration, CNa+ is the 
bath sodium concentration, Ccz- is the intra-tissue chloride concentration, and 
Ccz- is the bath chloride concentration. Since charge neutrality requires that the 
sum of all charges inside the cartilage tissue are a net of zero, 
FCD + CNa+- CCL-+ CcA = 0 Equation 5.2 
Where FCD is the intra-tissue (negative) fixed charge density contributed 
primarily by the GAGs. Combining Equations 1 & 2 and solving for C Na+ allows 
the partition coefficients to be calculated: 
K _ CcA cA--
ecA 
K - CNa+ 
Na+ - CNa+ 
61 
Equation 5.3 
KcAz+ and KcA4+ were each plotted as a function of KNa+ according to their 
relationship shown in Equation 1103, where: 
log(ccA) 
Z = CcA 
log(CNa+) 
CNa+ 
Equation 5.4 
and a nonlinear least-squares method was used to estimate the net charge (Z) on 
the CA2+ and CA4+ (MATLAB®, Math Works). 
5.2.2 Diffusivity of cationic contrast agent analogs in cartilage 
Typically, solute diffusion through cartilage is measured by tracking the 
evolution of a solute in a downstream or desorption bath. Although the contrast 
agents are effectively "labelled" with iodine for measurement using CT, this 
equipment is sensitive to concentrations in the 1-100 mM range. More dilute 
solute concentrations must be detectable in order to investigate both transient 
and steady state diffusion (which provide information regarding the presence or 
absence of diffusion time lag and the diffusivity, respectively) Often, small 
quantities of solute are radiolabelled for this purpose. In this experiment, we 
prepared non-iodinated analogs of the contrast agents CA2+ and CA4+ using a 
similar synthetic protocol as published previously (Appendix A). These analogs, 
which were structurally identical to the CT contrast agents except for their lack of 
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-iodine molecules, yield fluorescence signal in the middle/long wave ultraviolet 
range (i\ex = 300 nm, i\em = 352-356 nm). This characteristic was used to detect low 
concentrations of the analogs, called CA2+01 and CA4+ 01, through cartilage 
tissue. The diffusion behavior was compared to that of the common fluorophore, 
fluorescein (i\ex = 494 nm, i\em = 514 nm). 
For the experiments, CA2+01 and CA4+ 01 solute solutions were 
prepared in 1x phosphate buffered saline (PBS) at 10 mM concentration, and also 
included a preservative cocktail as described previously. Fluorescein disodium 
salt (FS) (Sigma-Aldrich F6377, St. Louis, MO) was also prepared in lx PBS at 200 
f.lM. Each solution was adjusted to pH=7.4 with sodium hydroxide and was 
balanced to 400 mOsmol/kg with sodium chloride. All contrast agents were 
stored at 4 ac and protected from light when not in use. 
Bovine osteochondral plugs (n=24, 7 mm diameter) were cored under 
constant irrigation from the trochlear grooves of three adult cows. Half of the 
plugs (n=12) were mounted on a cryostat (Microm™ HM525, Thermo Fisher 
Scientific, Waltham, MA) using tissue embedding media (Tissue-Tek™, Thermo 
Fisher Scientific). After the removal of the superficial zone (top 100 f.lm of tissue), 
a 300 f.lm axial slice was cut from the middle zone of each plug. The resulting 
slices (7 mm diameter, 300 f.lm uniform thickness) were stored in PBS containing 
63 
preservative cocktail at -20°C until later use. 
In order to determine the partition coefficients of the non-iodinated 
contrast analogs and fluorescein, the cartilage from the remaining plugs (n=12) 
was removed from the subchondral bone using a scalpel. These cartilage disks 
were randomly assigned and equilibrated in 1.5 mL of either 200 ~M FS, 10 mM 
CA2+0I, or 10 mM CA4+0I (n=4 disks each) and incubated for 24 hours at room 
temperature (22°C). Following equilibration, the exposed edges of each disk were 
removed in order to reduce the influence of contrast adsorption to the cartilage 
surface in the partitioning measurements148. This was accomplished using a 
scalpel (to removed surface and deep cartilage) and a biopsy punch (to remove 
circumferential edges). The trimmed disks were then placed in 1 mL of PBS and 
left to desorb for 24 hours. Each desorption solution was aliquoted into a quartz 
cuvette (Sarna Cells, Atascadero, CA) and measured using a fluorometer (Photon 
Technology International, Edison, NJ) using 0.5 mm slit width for FS, 1 mm slit 
width for CA2+0I and CA4+0I; Aex:Fs= 494 nm, Aem:Fs= 514 nm; Aex:CA2+0I = 300 nm, 
Aem:CA2+0I = 356 nm; Aex:CA4+0! = 300 nm, Aem:CA4+0I = 352 nm. The concentration of 
desorbed solute was determined by comparison with a standard curve of serial 
dilutions for each bathing solution. Then, each cartilage disk was imaged using 
~CT using the parameters discussed previously. For each disk, tissue volume 
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was determined from the imaging data in which the cartilage was segmented 
using the Analyze™ software. Each disk was weighed, lyophilized, and re-
weighed to determine the tissue water content. The partition coefficients (K) 
were calculated using conservation of solute as follows125,126,149: 
Equation 5.5 
where V d represents the volume of the desorption bath, V£ is the fluid volume of 
the cartilage disk, Ca and Cd represent the solute concentration of the absorption 
and desorption baths, respectively. 
For the diffusivity measurements, each 300 ~-tm slice was thawed at room 
temperature for 2 hours, removed from the PBS, carefully blotted with laboratory 
tissue, and clamped in a custom diffusion chamber between two silicone o-rings 
(6.05 mm inner diameter). Upstream and downstream solution baths were 
connected with the cartilage slice in between (Figure 5.2), and stir bars were 
added to each chamber. For each diffusion run, the downstream bath was filled 
with 3 mL of PBS, inspected for leakage, and 27 mL of solute solution (200 ~-tM 
FS, 10 mM CA2+01, or 10 mM CA4+01) was added to the upstream bath such 
that the fluid levels on both the upstream and downstream baths were level. 
Both baths were continuously stirred for the duration of the experiment to 
reduce the formation of a stagnant fluid layer at the cartilage-solution interface. 
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Every two minutes, a small aliquot (300 f.lL, 10% of the volume) was removed 
from the downstream bath, placed in a quartz cuvette, and the fluorescence 
emission at the appropriate characteristic wavelength was measured with the 
fluorometer. After measurement, the aliquot was quickly returned to the 
downstream bath. The total time elapsed between aliquot removal and return 
was approximately 40 seconds. After 60-80 minutes of diffusion, the setup was 
dismantled and the cartilage slice was placed in a large volume of PBS to rinse 
residual solute. Each slice was measured 1-3 times, using a different solute each 
time. Serial dilutions of the upstream solute baths were also measured before 
and after each run to directly determine the solute concentration and to ensure 
that concentration changed negligibly over the course of an experiment. 
Following diffusivity measurements, each slice was rinsed in copious PBS for 24 
hours, weighed, lyophilized, and the wet and dry tissue masses were 
determined. The water content (% wet mass) was calculated and the GAG 
content(% wet mass) of each slice was measured using the colorimetric DMMB 
assay (Appendix B). 
Solute flux for each experiment was calculated as the slope of the linear 
relationship between normalized downstream concentration and diffusion 
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time103•13B--140• From the measured flux and partition coefficient, the diffusivity (D) 
of each solute in each slice was calculated using Fick' s Law, where: 
r = cpKD Cu-Co ~ cpKD Cu 
8 8 Equation 5.6 
Where f is the steady-state flux, cp is the tissue porosity, K is the partition 
coefficient, D is the diffusivity, Cu is the concentration of the upstream bath, Co is 
the concentration of the downstream bath, and o is the cartilage slice thickness. 
The steady-state flux can be related to the time derivative of the normalized 
downstream concentration (Figure 5.2B) by: 
8 (Co) Ar C/>KDA 
-- ---~--
8t Cu V05Cu 8V05 
Equation 5. 7 
Where A is the slice cross-sectional area through which diffusion occurs and Vos 
is the volume of the downstream bath. For each solute, the average D was 
calculated and compared through a one-way repeated measures analysis of 
variance (ANOV A) with Tukey HSD post-hoc analysis (SPSS vl7.0, IBM, 
Armonk, NY). For each diffusion run, the characteristic time lag (T lag, measured ) was 
taken as the y-intercept of the steady-state flux and was compared to the time lag 
predicted by Fick' s law, where103: 
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Tlag,predicted = 60 
Equation 5.8 
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5.3 Results 
5.3.1 Equilibrium partitioning of anionic and cationic contrast agents in 
cartilage 
More concentrated contrast agent solutions resulted in higher equilibrium 
intra-tissue concentrations in the cartilage ECM for all contrast agents. Owing to 
electrostatic repulsion between ioxaglate and the anionic GAGs in cartilage, 
ioxaglate was largely excluded from the tissue ( ~42% ). Intra-tissue ioxaglate 
increased linearly with concentration such that the contrast agent concentration 
in the cartilage tissue at equilibrium was consistently -58% of that of the 
surrounding ioxaglate bath (Figure 5.3). Conversely, the electrostatic attraction 
between the cationic contrast agents, CA2+ and CA4+, and GAGs resulted in 
significantly higher concentrations inside the tissue compared to the surrounding 
baths. For CA2+, the intra-tissue concentration scaled linearly with bath 
concentration, with cartilage plugs having approximately 18% higher intra-tissue 
concentrations at equilibrium compared to the bath concentration. For CA4+, 
intra-tissue concentration scaled nonlinearly with bath concentration; at low bath 
concentrations, the equilibrium tissue concentration was -6 times the bath 
concentration. At higher concentrations the uptake of the CA4+ in the tissue 
decreased, yet remained at least -20% higher than the bath concentration in the 
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-range observed in this experiment. Based on the apparent saturation of tissue 
with CA4+, an ECso = 23.6 mgl/mL was determined. As in classical receptor-
binding experiments, this value could provide an estimate of the apparent 
dissociation constant (or "relative Krl")116• 
However, Donnan equilibrium theory predicts that the partition 
coefficients for CA2+ and CA4+ will follow the partition coefficient for Na+ via 
the power law relation shown in Equations 1&4 where Z is the total charge on 
the contrast agent. The nonlinear least-squares fits for the partition coefficients of 
cations in bovine cartilage plugs predicted Z = 0.94 for CA2+ and Z = 3.71 for 
CA4+ (R2 = 0.55, and R2 = 0.95, respectively; Figure 5.4). 
5.3.2 Diffusivity of cationic contrast agent analogs in cartilage 
For each diffusion run, solute began to elute in the downstream bath 
between 5-15 minutes of diffusion, which was consistently 2-2.75 times the 
predicted time lag (Figure 5.5). Following each time lag, diffusion at steady-state 
was observed by virtue of a linear increase in downstream solute concentration. 
Solute diffusivity proceeded in the order of increasing D, CA4+01 < FS < 
CA2+01, with CA2+01 being statistically different than both fluorescein and 
CA4+01 (p < 0.001, Figure 5.6). For all three solutes, D was not statistically 
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-proportional to GAG content or water content (data not shown).The CA4+0I had 
the smallest range for D (:::: 35 ~m2/sec) and CA2+0I had the largest (:::: 130 
~m2/sec). 
5.4 Discussion 
An obstacle in using anionic CT contrast agents for GAG quantification is 
the high concentrations required to obtain diagnostic quality images. Being 
largely excluded from the tissue, high concentrations are needed in order to get 
enough contrast into the tissue to produce sufficient x-ray attenuation signal to 
generate a correlation with GAG content. We have shown previously that 
cationic contrast agents can be used to visualize articular cartilage even at very 
low iodine concentrations, and that sensitivity to GAG content is improved as 
compared to anionic contrast agents. These advantages are derived from the 
favorable electrostatic attraction, and this study further illustrates the affinity of 
cationic agents (especially CA4+) for anionic GAGs by demonstrating high 
contrast uptake in cartilage (K > 1). For CA4+ in particular, K > 6 at low contrast 
solution concentrations and saturation appears to occur at high solution 
concentrations. In in vivo applications, this affinity allows for clear distinction 
between cartilage tissue and surrounding contrast solution even when very low 
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concentrations are used. This could translate into accurate segmentation for 
quantification of GAG content and morphological parameters. We also anticipate 
that the low concentrations of the CA4+ could reduce potential toxicity. 
In this experiment, CA4+ uptake reached an apparent plateau at high 
concentrations, which allowed an ECso (Kd or effective dissociation constant) to 
be calculated. However, the analysis of the data in comparison to the uptake 
predications made by Donnan equilibrium theory reveals that Donnan theory 
accounts for the CA4+ uptake seen in this experiment. That is, Donnan theory 
predicts a charge of +3.71 for the CA4+. This predicted valence is close to the 
agent's formal charge of +4, and the discrepancy may be due to incomplete 
ionization of the terminal amines of the CA4+, yielding a molecule that is, on 
average, slightly less than +4 charge. Indeed, separate measures of pKa values for 
CA4+ suggest that one (of several) pKa values for CA4+ is around 8 (unpublished 
data). Given this result, the calculated dissociation constant does not likely 
represent any specific affinity for the CA4+ and cartilage ECM, but rather the 
contrast uptake is attributable simply to electrostatic interactions. These results 
are similar to previous findings for a small trivalent cation which also partitioned 
according to Donnan equilibrium103. For the CA2+, Z was determined with less 
confidence (moderate R2) and the value Z = 0.94 was much lower than expected. 
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This could potentially also reflect incomplete ionization, although further 
investigation into this finding is warranted. 
Likewise, in the diffusivity experiment the measured time lag for each 
contrast agent was of the same order of magnitude as those estimated by Fick' s 
law of diffusion, which suggests that contrast agent molecules were not 
experiencing a strong binding affinity for sites in cartilage103• Had any of the 
solutes exhibited a binding affinity to sites in cartilage, we should have observed 
very long time lags (lO's or lOO's of minutes), compared to the relatively short 
time lags (-10 minutes) that were observed139•140• The consistent difference 
between measured and predicted time lags may be due to the experimental 
apparatus which, containing a short tubular connector between cartilage disk 
and downstream bath, may have caused some delay in detecting evolved solute 
in the downstream bath (despite constant stirring in the bulk solution). 
However, we did find a significantly slower diffusivity for CA4+01 than 
for CA2+01, which could be attributable to differences in molecular weight (MW 
= 593 vs. 305 Da) and/or charge. The diffusivities measured for FS were within a 
comparable range of literature values for the similar solute fluorescein 
isothiocyanate25•126 and similarly-sized tetramethylrhodamine145•150 validated the 
experimental approach1. The measured diffusivity for CA2+01 is similar to that 
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reported for commercially available anionic contrast agents, despite having 
slightly smaller molecular weight and cationic valence (though the value of such 
is in question, as discussed previously). Future studies should investigate 
diffusion with a similarly sized, non-ionic or anionic, non-interacting solute to 
elucidate whether the high cationic valence on the CA4+01 is a significant 
determinant of its slower diffusion. Regardless, this finding has important 
implications for the clinical translation of this technique. Although most contrast-
enhanced imaging studies show promising results when conducted ex vivo at 
diffusion equilibrium, reaching diffusion equilibrium in vivo may not be possible 
in all scenarios. For some research models, such as those with very thin cartilage 
tissues (mouse or rabbit, which have 100 and 300 flm tissue thicknesses 
respectively) diffusion equilibrium may be achieved fairly quickly151 . For 
instance, given D - 52 flm2/sec for CA4+, the characteristic diffusion time 
constant of tissue 100 flm thick would be - 30 seconds, and equilibrium would be 
achieved in 3-5 time constants (just a few minutes). On the other hand, for thicker 
tissues like human and equine (1-3 mm), the time to equilibrium could range 
from 6-12 hours or even longer, which is not feasible for use in the clinic (it being 
logistically impractical for a patient to report to the clinic on separate days for 
intra-articular injection and scanning, but also because it is impossible to keep a 
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constant-concentration reservoir of injected contrast agent inside the joint space 
for so long). These findings suggest that, in order to be diagnostically useful, CT 
contrast agents will need to yield sensitive and reliable quantitative information 
well before diffusion equilibrium is reached. A few reports have established this 
possibility with anionic contrast agents, and in subsequent chapters we will 
evaluate the capability of cationic contrast agents to perform as a quantitative 
probe prior to diffusion equilibrium. 
There are some important imitations to the current experiment. Ideally, 
both binding and diffusivity experiments would be conducted using a very small 
concentration (nM) of radiolabelled solute, which allows for better measurement 
precision at low concentrations. For this experiment, we utilized fluorescent 
analogs to the iodinated contrast agents. Although these analogs were identical 
in structure to the agents with the exception of their lack of iodine, this exclusion 
reduced the solute molecular weight by approximately 55% in both cases. This 
difference is not inconsequential, as molecular weight has been shown to 
influence, though not always predictably, solute diffusivity125,126• Future 
experiments should investigate the diffusion of the iodinated CA2+ and CA4+ in 
cartilage directly, perhaps using a modelling approach. Additionally, contrast 
diffusivity of the cationic agents has not yet been measured in human tissue, 
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-which can be compositionally and functionally different from commonly used 
animal models11.152- 154• Likewise, in this experiment diffusion proceeded through 
cartilage specimens that were intentionally homogenous and of small surface 
area. Solute equilibration across an intact joint surface, where tissue thickness 
and ECM composition may vary with position, should be more robustly 
investigated to determine the degree to which solute diffusion or partitioning 
can yield reliable information about cartilage quality. 
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Figure 5.1: Chemical structures of the non-iodinated contrast agent analogs 
(A) CA2+01, MW = 305 Da; (B) CA4+ 01, MW = 593 Da; and (C) the common 
anionic fluorophore fluorescein disodium salt (FS), MW = 332 Da. 
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Figure 5.2: Schematic showing the diffusion chamber design (A) and an 
example diffusion trace of CA4+01 through bovine articular cartilage (B). 
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ioxaglate. CA2+ and ioxaglate intra-tissue concentration was linearly 
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Figure 5.4: Donnan equilibrium modelling showing the partition 
coefficients of CA2+ and CA4+ as a function of sodium ion partition 
coefficients. Nonlinear least-squares best fits suggest a valence (Z) on the 
CA2+ and CA4+ as Z = 0.94 and 3.71, respectively, compared to their 
theoretical values (Z = 2 and 4, respectively). 
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Chapter 6: Contrast-Enhanced Computed Tomography Reflects Biochemical 
Content and Mechanical Properties of Human Femoral Head Cartilage 
6.1 Introduction 
Currently, osteoarthritis (OA) is diagnosed in the clinic based on 
symptoms such as pain, swelling, and abnormal joint function including 
stiffness, locking, and reduced mobility. To assist in diagnosis, radiographs are 
often taken of the affected joints to better elucidate changes in joint structure 
such as joint space narrowing, the presence of osteophytes, or that of 
subchondral bone sclerosis. These symptoms and radiographic findings appear 
late in the disease, which leaves clinicians with very few effective treatments to 
administer to expectant patients. Pain-relieving strategies (oral NSAIDs, steroidal 
injections) can help reduce patient discomfort and viscosupplementation can 
provide temporary relief for some patients, though the efficacy of the latter is 
disputed97- 99• While these strategies can in some cases temporarily mitigate OA 
symptoms, they do not address the root cause of the disorder. Some lifestyle 
changes may be helpful for decelerating the progression of OA, such as weight-
loss efforts and moderate exercise as part of a healthy lifestyle, but many patients 
suffering with severe OA (especially of the knee and hip) only find true relief 
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from partial or total joint arthroplasty. In the U.S., over 250,000 hip arthroplasties 
are conducted annually2• Especially given the aging American population, OA 
poses a significant public health problem for which there are clearly few, very 
costly, and only moderately effective therapies available. Unfortunately there is 
no cure for OA, but early diagnosis may provide opportunities for interventions 
that can truly ameliorate disease progression rather than treating the late-stage 
symptoms. Importantly as well, diagnosis and monitoring of early OA may 
provide both clinicians and researchers with a heretofore unavailable 
opportunity to develop better therapies. 
To this end, many musculoskeletal imaging studies in the last 15 years 
have focused on techniques, which promise to yield sensitive diagnostic 
information regarding cartilage health. Many of these techniques employ 
contrast enhancement (delayed gadolinium enhanced MRI of cartilage, or 
contrast-enhanced computed tomography) while others are non-contrast 
techniques (T2, Tlrho, and sodium MRI). Contrast-enhanced techniques, in 
particular, are of interest because the diffusion of an ionic contrast agent into 
cartilage tissue permits quantification of cartilage's natural fixed charge density 
contributed by glycosaminoglycans (GAGs), a key constituent in cartilage 
extracellular matrix (ECM). The anionic fixed charge density contributed by 
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GAGs in cartilage immobilizes water, and hence plays a critical role in 
maintaining fluid pressurization and consequent tissue compressive stiffness. In 
fact, since GAG content often decreases as an early change in OA (resulting in 
more compliant cartilage), GAG content can be used a biomarker for cartilage 
health. Many studies using delayed gadolinium enhanced MRI of cartilage 
( dGEMRIC) and contrast-enhanced computed tomography (CECT) have shown 
that ionic contrast agents act as mobile probes which diffuse into cartilage in 
proportion to GAG content, rendering an image that contains valuable 
information about the tissue's relative health. Some studies have also shown that 
ionic contrast agent partitioning correlates with cartilage mechanical properties 
such as equilibrium compressive modulus6•14 and coefficients of friction14, which 
is diagnostically useful. Soft, high friction, GAG-depleted tissue is identifiable 
with these techniques, and their promise for clinical diagnosis of OA is clear. 
However, most studies to date have been conducted in the laboratory on excised 
cartilage specimens, and extensive validation has not been done using intact 
joints, in vivo subjects, or even with human cartilage. In this experiment, the 
hypothesis was that both a cationic (CA4+) and an anionic (ioxaglate) iodinated 
contrast agent would be effective for measuring the GAG content and 
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mechanical properties of human femoral head cartilage by CECT both using 
high-resolution micro computed tomography and using clinical CT. 
6.2 Materials and Methods 
Two human hemi-pelvis specimens (ages 40 and 61, female and male 
respectively) were obtained and thawed at 4°C (Med-Cure, Portland, OR). 
Following thawing, a hole was drilled in each specimen's distal femur and iliac 
crest, through which nylon string was threaded. Each hemi-pelvis was laid upon 
a surgical table, the treads were attached to 20 lb weights, and the weights were 
suspended over the edges of the table to provide traction force. This 
configuration was deemed necessary based on pilot experiments, which revealed 
that fluid injected into the hip joint did not reliably or adequately contact the 
femoral head and acetabular cartilages in the absence of distraction force. Under 
joint distraction, two central venous catheters (9-French) were installed into each 
hip joint capsule (Arrow® ErgoPack™ System, Teleflex Medical, Research 
Triangle Park, NC) in order to create an inflow and outflow port (Figure 6.1A). 
Approximately 200 mL of saline (400 mOsmol/kg) wash washed through the 
joints via the inflow and outflow ports to confirm access to the joint space and to 
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remove synovial fluid. Distraction force was removed briefly, and each joint was 
manually compressed to exude as much of the residual saline as possible. 
For CECT imaging, each joint was connected to a syringe containing 80 
mgl/mL ioxaglate solution (Hexabrix-320®, Mallinckrodt, Hazelwood, MO) via 
the inflow port. The outflow port was clamped shut and the joint was 
pressurized to 150 mmHg with ioxaglate solution. An in-line clinical pressure 
transducer (LogiCal® Pressure Monitoring Kit, Smiths Medical, Norwell, MA) 
and blood pressure monitor were used to gauge and adjust the fluid pressure as 
it was manually cyclically varied at 1 Hz from approximately 90-210 mmHg for 5 
minutes. After this time, the fluid pressure was released to atmospheric pressure 
(with approximately 10 mL of contrast agent residing in the joint capsule) and 
then the inflow port was clamped shut. After approximately 1 hour of diffusion 
time, each joint was scanned, under distraction force, in a clinical CT instrument 
(SOMATOM Sensation 64, Siemens Healthcare, Malvern, PA) at 120 kVp, 219 
rnA, 500 mm field-of-view with 512x512 matrix yielding 0.727 mm in-plane 
effective resolution, 0.75 slice thickness, 0.5 helical pitch, and soft (B20f) 
reconstruction kernel to improve the signal-to-noise ratio for soft tissue 
evaluation. Following imaging, each joint was left under distraction force at 
room temperature for an additional 11 hours and imaged again. Then, to remove 
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the contrast agent, the inflow and outflow ports were connected to a peristaltic 
fluid pump system (Masterflex™, Cole-Parmer, Vernon Hills, IL) and copious (> 
10 L) of saline was rinsed through each joint over the course of eight hours 
(approximately 50 mL/minute). In pilot experiments, this rinsing time frame was 
sufficient both to remove the contrast agent from the joint space and to remove 
the contrast agent from the femoral head and acetabular cartilages. Following 
rinsing, the distraction force was again removed and each joint was manually 
compressed to remove the residual saline. The same contrast infusion and 
imaging protocol was followed using CA4+ at 24 mgl/mL as the contrast agent. 
After imaging, the joints were disarticulated and the femoral heads were rinsed 
in copious saline to remove the residual CA4+ from the cartilage. 
Six osteochondral plugs (7 mm diameter) were harvested from each of the 
two femoral heads using a diamond tipped cylindrical cutter under constant 
irrigation (Figure 6.1B). Each plug was rigidly clamped in a mechanical testing 
apparatus (Enduratec3230, BOSE, Eden Prairie, MN) and a compressive pre-load 
of 5 N was applied between the cartilage surface and a nonporous UHWPE 
platen to ensure complete contact between the cartilage and platen. While 
immersed in saline, each plug was subjected to 4 incremental 5% compressive 
strain steps (5 f.lm/sec) in unconfined compression with stress relaxation (45 
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minutes) intervening between strain steps. A collection rate of 10Hz was used to 
record the force and displacement data, and a linear fit to stress vs. strain at each 
equilibrium was used to calculate the equilibrium compressive modulus for each 
cartilage specimen6,14• Following recovery overnight in saline, each plug was 
subjected to torsional friction by applying an 18% compressive strain against a 
polish aluminum platen (5 11-m/sec), relaxing for 70 minutes, and rotating 720° at 
5°/sec (an effective velocity of 0.3 mm/sec) to derive static and kinetic coefficients 
of friction14,155 • Force, displacement, torque, and rotational data were collected at 
10Hz. Coefficients of friction (!1-) were calculated as follows: 
T 
~ = (RN) where T = torque, R = plug radius, Equation 6.1 
N = normal force, and: 
!1-static: the maximum value of 11- for the first 10° of rotation 
!1-static_equilibrium: computed using the maximum value of T from the 
first 10° of rotation and N as the normal force at the end of the last 
relaxation period 
!1-kinetic: the average value of 11- during the second 360° of rotation 
After recovering the plugs overnight in saline, they were immersed in 
ioxaglate solution (80 mgl/mL) for 24 hours and then CECT imaged (!l-CT40, 
Scanco Medical AG, Briittisellen, Switzerland) at an isotropic voxel resolution of 
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36 ~m, 70 kVp, 114 ~A, and 300 ms integration. The plugs were rinsed of the 
ioxaglate in saline for 24 hours, immersed in CA4+ solution (12 mgi/mL) for 24 
hours and then re-imaged. After rinsing the plugs in saline for 24 hours to 
remove the CA4+, the GAG content (as a% of wet tissue mass) of each specimen 
was measured using the 1,9-dimethylmethylene blue assay (Appendix B). 
In addition to harvesting osteochondral plugs, the remaining femoral 
head surfaces were imaged again, without contrast, using clinical CT. These post-
harvest images were aligned with the contrast-enhanced intact joint images using 
image registration and analysis software (Analyze®, AnalyzeDirect, Overland 
Park, KS). For both femoral heads, a mask was created with the post-harvest 
image, which enabled accurate segmentation of the clinical CT image data at the 
locations of the harvested plugs. Thusly, the mean x-ray attenuation of each 
cartilage specimen in the clinical CT image was extracted using a semi-automatic 
contour based algorithm and expressed in Hounsfield Units (HU). For the ~CT 
plug images, the cartilage was also segmented from the subchondral bone using 
a semi-automatic contour based algorithm. The mean x-ray linear attenuation 
coefficient of each cartilage plug was converted to Hounsfield Units (HU) by 
normalizing to that of water scanned in a similar geometry at the same settings 
on the ~CT40. Univariate linear regression (SPSS v17.0, IBM, Armonk, NY) was 
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performed to evaluate the relationship between clinical CT and f1.CT attenuation 
(HU), GAG content (% of wet weight), equilibrium compressive modulus 
(E,MPa), and coefficients of friction (f-lstatic, f-lstatic_equilibrium, and f-lkinetic). 
6.3 Results 
After one hour of diffusion, minimal CA4+ or ioxaglate was detectable in 
the thin femoral head cartilage, but the solutions were visible in the joint space 
(Figure 6.2A). For both contrast agents, the cartilage appeared as a negative 
space between the highly attenuating contrast agent solution and the even higher 
attenuating subchondral bone. After 12 hours of diffusion, both contrast agents 
diffused into the cartilage (Figure 6.2B). For CA4+, the cartilage was more easily 
distinguishable at 12 hours of diffusion, while for ioxaglate the cartilage was 
more readily identified at one hour of diffusion. Using ioxaglate, the labrum was 
also clearly visible at both one hour and 12 hours of diffusion. 
Comparing CECT data to biochemical content, 79% of the variation in 
f1.CT attenuation was attributable to GAG content (R2 = 0.79, p < 0.001) for 
ioxaglate and 89% of the variation in f1.CT was attributable to GAG content (R2 = 
0.89, p < 0.001) for CA4+ (Figure 6.3A). Relating CECT data to tissue stiffness, 
82% of the variation in f-lCT attenuation was attributable to equilibrium 
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compressive modulus (R2 = 0.82, p < 0.001) for ioxaglate and 54% of the variation 
was attributable to modulus (R2 = 0.54, p = 0.01) for CA4+ (Figure 6.3B). CECT 
attenuation correlated less strongly, and not always statistically significantly, to 
coefficients of friction !-lkinetic, !-lstatic, and !-lstatic_equilibrium (R2 = 0.31, 0.44, and 0.19 
respectively for ioxaglate, Figure 6.4A; R2 = 0.48, 0.54, and 0.31 respectively for 
CA4+, Figure 6.4B). 
Despite the clear uptake of contrast agents in the clinical CT images after 
12 hours of diffusion, clinical CECT attenuation did not correlate to GAG 
content, modulus, or 1-1 in any cases at either one or 12 hours of diffusion (data 
not shown). 
6.4 Discussion 
Both ioxaglate and CA4+ were taken up in human femoral head articular 
cartilage after 12 hours of diffusion, as expected. Relatively little was taken up at 
one hour. For ioxaglate, the cartilage was identifiable in clinical CECT scans at 
one hour of diffusion, which is advantageous from a clinical perspective. 
However, quantitative analysis of the clinical imaging data revealed that 
ioxaglate was not able to quantify biochemical content nor mechanical properties 
at n=6 regions around two femoral head surfaces either at one or 12 hours of 
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diffusion. Similarly, CA4+ was not able to quantify any of the parameters at 
either time point. 
Conversely, f..!CT data revealed that both contrast agents are adept at 
reflecting GAG content, equilibrium compressive modulus, and coefficients of 
friction using high resolution imaging at diffusion equilibrium. This data is 
similar to a previous study using bovine osteochondral plugs, and supports 
those findings while extending the proof-of-concept to human cartilage tissue14• 
This step is important to establishing the feasibility of using CECT as a clinical 
tool, since it explores CECT for quantifying cartilage functional performance in 
actual human cartilage, which can be different in several ways compared to 
bovine11,152- 154• Indeed, in this experiment the coefficients of determination for 
coefficients of friction are weaker than those previously reported14, perhaps 
reflecting the heterogeneity of the human articular cartilage used compared to 
bovine. 
Still, these data only incrementally advance the potential feasibility of 
CECT as a clinical tool given that the clinical CECT imaging did not reflect either 
biochemical content or mechanical properties. Indeed, this emphasizes the 
considerable challenge in scaling up CECT to clinical use. These findings could 
be owing to several reasons, all of which represent complications to the clinical 
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translation of CECT. First, the spatial resolution of current clinical CT 
instruments is very low relative to f.tCT scanners. That is, especially for thin 
cartilages(< 1.5 nun) in the human femoral head, the cartilage can be difficult to 
distinguish from the surroundings and both partial-volume artifacts and 
contouring errors are more prone and have larger impact on quantitative data. 
Second, the relatively small region-of-interest (ROI) size (both in thinness and 
small diameter) used in this study may have adversely affected the 
quantification ability, since smaller ROis are disposed to greater effects from 
image noise, which is substantial in CT. Third, although femoral head cartilage 
is thin (relative to that of the patellofemoral joint), it is not clear that 12 hours of 
diffusion was sufficient to reach diffusion equilibrium in the present model. This 
needs to be more thoroughly investigated, as does the impact of incomplete 
diffusion on contrast agents' ability to quantify cartilage health and functional 
performance. Fourth, the hip is also a difficult model for CECT validation 
because the femoral and acetabular surfaces are very tightly conforming. In this 
experiment, a large distraction force was applied to each hip joint in order to 
provide sufficient contrast agent solution interposed between the cartilage 
surfaces. In vivo, this protocol will be less feasible and so it will be challenging to 
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ensure that the cartilage surfaces are uniformly exposed to contrast agent 
solution. 
Although clinical CECT imaging of the hip would be valuable from a 
clinical perspective, since alternative imaging strategies (specifically MRI) of the 
hip have unique shortcomings such as magnetic field inhomogeneity in the 
pelvic region due to large and variable body habitus156•157, clinical CECT 
development is more likely to be successful in other joints. The knee joint, in 
particular, features larger, thicker cartilage surfaces, which do not obstruct each 
other from contrast exposure to the same degree. For these reasons, future 
translational experiments will investigate CECT efficacy first in human and 
equine knee joints. 
(A) (B) 
Figure 6.1: Human hemi-pelvis specimens were tested, intact, for contrast 
enhancement of the femoral head cartilage (A). Following hip joint 
disarticulation, osteochondral cores (7 mm diameter) were harvested from 
various locations around the surfaces (B). 
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(A) 
Figure 6.2: Human hips enhanced with CA4+ (A) and ioxaglate (B) for 
visualizing the articular cartilage. At 1 hour of diffusion (tops), the femoral 
head cartilage appears as a lower attenuating space between the pooled 
contrast agent and the subchondral bone for both contrast agents. At 12 
hours of diffusion (bottoms), contrast agent has simultaneously diffused 
into the cartilage (as noted by its higher attenuation) and out of the joint 
space (as noted by its lower attenuation). For ioxaglate, the labrum is also 
visible at both time points. 
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Chapter 7: Clinical Contrast-enhanced Computed Tomography in an Equine 
Femoropatellar Joint Model Distinguishes Osteoarthritis Disease State 
7.1 Introduction 
In horses as in humans, osteoarthritis (OA) is a common cause of impaired 
locomotion. Particularly in race horses, where athletic performance is of utmost 
importance, OA is indeed the most common cause of lameness and puts an 
animal at risk of early retirement158• Being the largest and most complex joint in 
horses, the stifle joint is particularly susceptible to injury leading to hindlimb 
lameness159 . 
Equine osteoarthritis progresses in a similar trajectory as for humans. One 
of the early makers for OA is a loss of glycosaminoglycan (GAG) content from 
the cartilage, which increases the tissues' hydraulic permeability and reduces its 
resistance to compressive loads. Increased permeability subsequently increases 
collagen fibrils' participation in load bearing, which leads to fibrillation and 
consequent irreversible damage to the cartilage such as thinning and lesioning. 
Concurrent changes to the subchondral bone such as sclerosis, subchondral bone 
remodeling, and osteophytes may also occur160,161 . 
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Because cartilage tissue is avascular, its ability to self-heal is poor in 
comparison to most other tissues. Therefore, OA diagnosed at a late stage (where 
widespread, macroscopic damage has already occurred) is exceedingly difficult 
to treat. Indeed, methods for cartilage repair and improved healing in 
horses151,162- 169 is an important clinical research goal in equine veterinary practice. 
Accordingly, a survey of equine veterinarians reveals that OA is one of the most 
important diseases requiring further research170• 
One complicating factor related to the development of tissue repair 
strategies is the difficulty in longitudinally assessing a treatment's effects over 
time. A sensitive imaging modality that can track cartilage morphology and 
quality over time would enable facile evaluation of new tissue repair strategies. 
In recent years, magnetic resonance imaging (MRI) as well as contrast-enhanced 
computed tomography (CECT) are being used for this purpose. Both imaging 
techniques present significant obstacles, however. MRI imaging on equine joints 
is complicated by their large body habitus, which can be logistically challenging 
as well as can complicate the application of a homogeneous magnetic field. 
Likewise, the extended acquisition times of MRI requires that equine patients be 
anesthetized for longer periods of time, which incurs added risk. CECT applied 
to equine specimens shows promise ex vivo for indicating cartilage biochemical 
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composition and mechanical performance171, although CT imaging also has the 
disadvantage of ionizing radiation exposure. 
Most applications of CECT utilize a commercially available anionic 
contrast agent (ioxaglate, iothalamate, etc.) which partitions in cartilage in 
inverse proportion to GAG content and reflects mechanical properties4'6'10• 
However, an alternative strategy has been developed which utilizes a cationic 
contrast agent which is highly taken up in cartilage due to electrostatic attraction, 
and subsequently partitions in direct proportion to GAG content and mechanical 
properties7,13,14. The cationic strategy has been validated ex vivo, suggesting that 
cationic agents can be applied at much lower concentrations (lower effective 
dosing) and yield sensitive quantitative information. However, the technique has 
not been fully investigated in intact joints from a large animal model. 
Towards this aim, a cationic contrast agent was injected into intact equine 
stifle joints and assessed the cartilage in the femoropatellar joint using a clinical 
CT scanner. Subsequently, the clinical CT results were compared to CECT 
imaging performed using high resolution micro computed tomography as well 
as measurements of equilibrium compressive modulus and GAG content. 
Specifically, the hypotheses were that 1) an intra-articular injection of a cationic 
contrast agent with 4 positive charges (CA4+) would yield high-quality 
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mid-femur to mid-tibia with a clinical CT scanner (Gemini TruFlight Big Bore 
I 
PET/CT, Philips Healthcare, Andover, MA) at 140 kVp, 177 rnA, 600 mm field-of-
view with 1024x1024 matrix yielding 0.202 mm in-plane effective resolution, 0.8 
slice thickness, 0.5 helical pitch, and sharp (B70f) reconstruction kernel. 
Following imaging, the joints were disarticulated and osteochondral plugs were 
harvested (7 mm diameter) from the patellar and femoral trochlea surfaces. Each 
osteochondral plug was immersed in a large volume of saline (400 mOsmol/kg) 
with a preservative cocktail containing protease inhibitors, antibiotics, and 
antimycotics (5 mM Benzamidine HCl, 5 mM EDTA both of Sigma-Aldrich, St. 
Louis, MO; 1x Antibiotic-Antimycotic, Life Tech, Carlsbad, CA) at room 
temperatute overnight in order to remove residual CA4+. The plugs were 
subsequently frozen at -20°C in fresh saline with preservative cocktail until use 
in the next phase of the experiment. 
In order to assess the performance of CA4+ in equine cartilage, the equine 
plugs were thawed at room temperature for 2 hours prior to the experiment. A 
solution of CA4+ at 8 mgl/mL was prepared, and each plug was immersed in 2 
mL (approximately 20x cartilage volume) of the CA4+ solution. The specimens 
were incubated at room temperature for 24 hours, which has been shown in 
previous experiments to well exceed the required equilibration time for this 
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specimen geometry116• Following incubation, the specimens were scanned using 
micro computed tomography (f-1-CT40, Scanco Medical AG, Briittisellen, 
Switzerland) at 70 kVp, 114 rnA, 300 ms integration, and 36 f-1-ID isotropic voxel 
resolution. The CT images were converted to DICOM format and imported into 
analysis software (Analyze®, AnalyzeDirect, Overland Park, KS), which enabled 
semi-automatic contour-based segmentation of the cartilage from the 
subchondral bone. The mean x-ray linear attenuation coefficient of each cartilage 
pl~g was converted to Hounsfield Units (HU) by normalizing to that of water 
scanned in a similar geometry on the f-1-CT40. Following imaging, each cartilage 
plug was rinsed in a large volume of saline with preservative cocktail for 24 
hours at room temperature. Then, each cartilage specimen was sharply dissected 
from the subchondral bone, weighed, lyophilized, and digested in papain (1 
mg/mL in 50 mM sodium phosphate, 5 mM EDT A, and 2 mM dithiothreitol, with 
a pH of 6.8) at 65°C overnight. The 1,9-dimethylmethylene blue assay was used 
to determle mean GAG content (as a % of wet weight) for each specimen 
(Appendix B). 
In addition to harvesting osteochondral plugs, the remaining patellar and 
trochlear surfaces were imaged without contrast (SOMATOM Sensation 64, 
Siemens Healthcare, Malvern, PA) at 120 kVp, 219 rnA, 500 mm field-of-view 
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with 512x512 matrix yielding 0.727 mm in-plane effective resolution, 0.75 slice 
I 
thickness, 0.5 helical pitch, and sharp (B70f) reconstruction kernel. These post-
harvest images were aligned with the contrast-enhanced intact joint images using 
image regJstration in the Analyze software (Figure 7.1). A mask was created with 
the post-harvest image, which enabled accurate segmentation of the clinical CT 
image data at the locations of the harvested plugs. The mean x-ray attenuation of 
each specimen in the clinical CT image was extracted and expressed in HU. Plug 
GAG content was compared to both ~CT and clinical CT attenuation for each 
plug. 
7.2.2 Clinical CT and pCT in cartilage from an equine femoropatellar defect 
model 
To r vestigate the ability of cationic CECT to distinguish within a broad 
range of cartilage qualities, a second experiment was conducted in which 
femoropatellar defects were created and imaged. All procedures were reviewed 
and approved by the Animal Care and Use Committee (IACUC) at Colorado 
State University. A young adult horse (aged 4 years) was catheterized in the 
jugular J ein and received perioperative antibiotics and anti-inflammatory 
medications (2.2 mg/kg ceftiofur sodium IV [Pfizer, Pharmacia & Upjohn Co., 
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New Yori NY]; 4.4 mg/kg phenylbutazone N [VetOne, MWI, Boise, ID]). The 
horse wa1 pre-medicated with xylazine hydrochloride (0.5 - 1.1 mg/kg N 
[AnaSed, r oyd, Decatur, lA]) and 5% guaifenesin (50 - 100 mg/kg IV [US 
Compounr ing, Conway, AR]). General anesthesia was induced with ketarnine 
hydrochlo~de (2.2 mg!kg IV [Ketaset, Fort Dodge Animal Health, Fort Dodge, 
lA]) and maintained by inhalation of isoflurane (Fluriso, VetOne, MWI) in 100% 
oxygen. B~th hind limbs were secured to leg stands fixing both stifles into full 
extension. Both stifles were clipped of hair and aseptically prepared and draped. 
An arthrokcopic portal was created between the lateral and middle patellar 
ligaments as described previously172• An instrument portal was created by 
triangulation using an 18 gauge x 8.9 em spinal needle. The left stifle was 
randomly assigned to receive the chondral defects while the right stifle was 
sham-operated. A 15 mm circular chondral defect (M1) was created on the 
medial troL ear ridge of the femur with an osteochondral biopsy punch (DePuy 
Mitek, Rar arn, MA). The articular cartilage was removed with curettes and 
Ferris-Smith rongeurs. The calcified cartilage layer was left intact to ensure 
marrow ell ments did not contribute to articular cartilage healing. Two defects 
(Ll, L2) wL e created on the lateral trochlear ridge of the femur with a 10 mm 
I 
osteochondral biopsy punch (DePuy Mitek); one proximally and one distally, 10 
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mrn apart. The articular cartilage from the distal defect (L2) was removed 
leaving the calcified cartilage layer intact, while the proximal defect (L1) had the 
calcified cartilage layer removed to allow partial healing of the defect. The right 
stifle was operated similarly, but no chondral defects were created. The incisions 
were closed with 2-0 nylon in a simple interrupted pattern. Adhesive bandages 
were applied to the incisions and the horse recovered from general anesthesia. 
Postoperatively, the horse received phenylbutazone (4.4 mg/kg PO every 24 
hours [VetOne, MWI, Boise, ID]). The horse was maintained on stall 
confinement (12 feet x 12 feet) following surgery until the end of the experiment. 
The sutures were removed 14 days following surgery. At 47 days, the horse was 
humanely euthanized with an overdose of sodium pentobarbital (88 mg/kg IV, 
Beuthanasia-D, Merck Animal Health, Summit, NJ) and both stifles were injected 
with 100 mL of CA4+, placed through full range of motion to disperse the 
contrast agent, incubated for 36 hours at 4°C, and imaged as described in section 
7.2.1 above. 
Subsequently, osteochondral plugs were harvested from the trochleae of 
both left and right stifles. The same plug harvest and image registration 
protocols were used as described previously. An Outer bridge score was assigned 
to each osteochondral plug before freezing at -20°C until use in the experiment. 
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After thal ing, a subset of the osteochondral plugs was subjected to a stress-
relaxation compressive regimen. Each plug was rigidly clamped in a mechanical 
testing api aratus (Enduratec3230, BOSE, Eden Prairie MN) and a compressive 
pre-load was applied between the cartilage surface and a nonporous UHWPE 
platen to ensure complete contact between the cartilage and platen. While 
immersed in saline, each plug was subjected to 4 incremental 5% compressive 
strain steps (0.333 %/sec) in unconfined compression with stress relaxation (45 
minutes) intervening between strain steps. A collection rate of 10Hz was used to 
record the force and displacement data, and a linear fit to stress vs. strain at each 
equilibrium was used to calculate the equilibrium compressive modulus for each 
cartilage specimen. Following mechanical testing, all of the plugs were 
equilibrated in CA4+ at 8 mgi/mL for 24 hours, imaged using !J.CT as described 
previously rinsed in saline, and prepared for the DMMB assay as also described 
previous!) 
7.3 Results 
7.3.1 Clinical CT and pCT in healthy equine femoropatellar cartilage 
In 1 e first experiment, clinical CT images show high uptake of the CA4+ 
in the patellar and trochlear cartilages (Figure 7.2) of one horse stifle. The 
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cartilage ir easily distinguishable from both the subchondral bone and the 
surrounding soft tissues of the joint. Rendered as a color map for enhanced 
visualization (Figure 7.2A), CA4+ partitioning in the trochlear cartilage increases 
with cartilage depth and is generally higher on the more proximal region. For the 
second stifle, incomplete contrast diffusion occurred due to the tight fit between 
the patella and trochlea (Figure 7.3). Since incomplete contrast diffusion could 
compromise the analysis (by yielding artificially low contrast uptake in some 
regions), the cartilage plugs harvested from the second stifle were not analyzed 
quantitatively. 
For the remaining stifle, ~CT attenuation correlated strongly with GAG 
content (Figure 7.4A; R2 = 0.84 for patella, R2 = 0.67 for trochlea, p < 0.0001 each). 
The CA4+ also partitioned in the plugs in direct proportion to GAG content, with 
high CA4+ uptake in the cartilage deep zones (Figure 7.4B). For the clinical 
images, however, the correlation between clinical CT attenuation and GAG 
content was weak and not statistically significant for the patellar surface (Figure 
7.5A). Key differences between ~CT and clinical CT may influence this large 
discrepancy (Figure 7.5B). 
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7.3.2 Clinical CT and pCT of cartilage from an equine femoropatellar defect 
model 
In the second experiment, joint disarticulation revealed that minimal 
defect heal~ng had occurred. The large full-thickness defect (M1) was completely 
denuded, the full-thickness+ calcified cartilage removed defect (L1) had a small 
amount of thin cartilage covering the subchondral bone, and the full thickness 
defect (L2)1 had a minuscule amount of cartilage ingrowth along the periphery 
(Figure 7.6A). The peri-defect area around M1 showed significant signs of 
thinning, fissuring, lesioning, and softening, extending approximately 18 mm 
from the circumference of Ml. The lateral defects did not show visually 
compromised peri-defect regions. The contralateral (right) stifle was smooth and 
visually healthy across the entire surface (Figure 7.6B). 
In the clinical CT images, CA4+ was also highly taken up in both trochlear 
and patellar cartilages. All three surgical defects were visually obvious (Figure 
7.7). The lateral defects (L1, L2) appear as gaps in the otherwise continuous 
cartilage sj rface and the medial defect (M1) appears as a large denuded area. 
GA(J; content, equilibrium compressive modulus (E), and f.lCT attenuation 
I 
corresponded to Outerbridge scores from the harvested plugs (Figure 7.8). f.lCT 
attenuation correlated moderately to strongly for both GAG content (R2 = 0.72 
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left, R2 = 0.67 right, p < 0.001 each) and E (R2 = 0.51 left, R2 = 0.62 right, p ~ 0.001 
each) (Figure 7.9). The correlations with GAG content were not statistically 
different between left and right (p = 0.147) nor were they different for E (p = 
0.150). 
Clinical CT attenuation corresponded to Outerbridge scores (Figure 
7.10A) and clinical CT attenuation correlated moderately with both GAG and E 
(R2 = 0.32, p < 0.001 and R2 = 0.44, p < 0.001, respectively) (Figure 7.10B&C). 
However, comparing the left and right stifles, clinical CT attenuation correlated 
moderate! to GAG content in the right stifle (control) alone but only weakly in 
the lef! stifle (defects) alone (R2 = 0.51, p < 0.001 and R2 = 0.11, p = 0.048, 
respective! ), which were statistically different (p = 0.011) (Figure 7.11A). The 
relationshi~ between clinical CT and E appeared to be consistent for both right 
and left stifles, though it was not quite statistically significant on the right 
probably due to lower sample size (R2 = 0.40, p < 0.001 and R2 = 0.22, p = 0.052, 
respectively) (Figure 7.11B) 
7.4 Discussion 
The first equine experiment established a strong relationship between 
equilibrium partitioned CA4+ and GAG content using !J.CT, which is similar to 
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previous reports in bovine cartilage7,13,14• For the clinical imaging, CA4+ injection 
into an infact joint resulted in high uptake of the cationic contrast agent as 
evidenced by visually good contrast between the cartilage, subchondral bone, 
and soft l sues of the joint space. However, the relationship between GAG 
content and clinical CT attenuation was difficult to quantify, as the correlations 
were not statistically significant. This finding could be owing to several factors, 
most impdrtantly the decreased spatial resolution of clinical CT compared to 
1-1CT in conjunction with the relatively small size of the cartilage specimens used 
I 
here. Clinical CT also provides a reduced range of attenuation values from the 
tissue, which can make quantification more difficult. Additionally, 1-1CT 
conducted rth specimens in air benefit from a higher contrast-to-noise ratio for 
cartilage regions, which makes them much easier to extract from the surrounding 
tissue, which minimizes the effects of partial volume artifacts and other 
segmentation errors. In clinical CT, the boundaries between tissues can be less 
well defined and more difficult to extract especially when complicated by 
relatively low spatial resolution. Luckily, higher resolution cone-beam extremity 
I 
CT scanners are appearing in clinic as of late, and with higher and isotropic voxel 
I 
resolution (0.2 mm, with a potential for 0.1 mm) they may greatly improve the 
possibilities for quantitative cartilage imaging173,174• 
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Givr these initial results, the rationale for the design of the second 
experimenf was to investigate a more broad range of cartilage qualities using 
CECT. In particular, the defect model enabled us to evaluate the ability of CECT 
with CA4+ to visually represent cartilage defects and quantitatively reflect 
cartilage quality. On both counts, the results are encouraging. Since the cartilage 
in general had a high uptake of the CA4+, the defect regions were very easily 
identifiable due to their lack of contrast. This finding suggests that CECT using 
CA4+ mal be adept at identifying cartilage lesions, which are indicative of 
moderate to severe OA. However, the small amount of cartilage growth in the L1 
defect was not visible, possibly because it was too thin relative to the scanner's 
spatial resolution or because the repair tissue had a very low GAG content, 
yielding a small uptake of CA4+. Additionally, just as GAG content and 
equilibriut modulus generally decrease as OA severity increases (e.g. increasing 
Outerbridge score), both equilibrium · ~CT attenuation and clinical CT 
I 
attenuation decreased correspondingly. In particular, the aim is in quantifying 
cartilage changes in the early and middle stages of the disease (representing, for 
instance pathology ranging from Outerbridge 1 to 3) and in this experiment, 
cartilage was distinguishable among these grades. That is, the CECT technique 
may be adept for preforming disease staging analyses. Also, clinical CT 
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attenuation correlated moderately with both GAG content and equilibrium 
compressive modulus, although there was some variability in these 
relationshi~s. Most importantly is to note that while CT attenuation correlated 
I 
with GAG content for the right stifle alone, it did not for the left alone. This 
finding hal significant implications for joint imaging, since diagnostic protocols 
would typl ally image only one joint. That is, if only cartilage locations across the 
left stifle hL been assessed due to suspected OA (e.g. pain and swelling caused 
by lesions), GAG content would have been less successfully quantified via CECT 
measurements. However, the clinical CT data does correlate well to equilibrium 
compressive modulus for both stifles taken individually and together, even while 
the mechJ ical stiffness of the right (uninjured) stifle cartilage is generally higher 
I 
than that of the left stifle. This result is promising, since tissue softening may 
indeed be a more functionally relevant (though more complex) measure of 
cartilage qJ ality than GAG content. 
Des~ite these generally promising results, however, there are some 
I 
limitations to this study. Primarily, this study utilized a very small number of 
joints for quantitative analysis. A larger study with multiple equine specimens is 
warranted r order to better address inter-animal variability. Additionally, this 
study did not compare quantitative clinical imaging performance for CA4+ to 
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that of iox glate (a commercially available, anionic CT contrast agent), which has 
been shol in previous studies to correlate with GAG content and/or 
equilibriul f1CT imaging. In these studies, however, large cartilage regions are 
generally L d in order to produce good correlations. In this study, 7 mm 
diameter , lugs were harvested since this size is similar to what is considered a 
critical sized cartilage defect. That is, lesions of this size in vivo are on the 
borderline of what is expected to heal and rather represents serious cartilage 
injury. , !her the CECT technique might be sensitive enough to detect inferior 
quahty cartilage of these clm1cally relevant siZes was of utmost mterestl75• 
Finally, tJ equine stifle joint model does not closely represent in vivo conditions. 
M . I 1 . u1 . h . · · "dl ost rmportant y, active vase ature m t e synovmm m vzvo rap1 y removes 
contrast al ent injected intra-articularly, so contrast agent diffusion kinetics into 
cartilage J ssue will strongly influence CECT measurements-especially those 
measuremL ts that are taken prior to diffusion equilibrium, which is likely 
unavoidab[e in vivo. 
Othl r challenges not addressed in this work may impact the translation of 
CECT to clb ic. For one, in the first experiment one of the stifles was not analyzed 
quantitati+ ly because of obstructed or incomplete diffusion, which presumably 
occurred simply because of the tight fit between the trochlea and the patella on 
I 
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that particular joint. Indeed, this diffusion obstruction may be difficult to avoid 
in practice, though may be somewhat alleviated by having patients move their 
joint during contrast diffusion so as not to create a "dead spot" of unenhanced 
cartilage. A more pressing concern, however, relates to the clinical impracticality 
of equilibrium partitioning in a whole joint. That is, for large subjects (horses, 
I 
humans, etc.) with relatively thick cartilage (1-3 mm), contrast agent may not 
diffuse quickly enough to reach equilibrium within a clinically feasible time 
frame. Some recent studies have investigated the quantitative capability of 
anionic contrast agents in CECT prior to diffusion equilibrium, and in future 
work this will be investigated for cationic contrast agents. 
In sum, the results of this study are encouraging in that CECT of cartilage 
using a cationic contrast agent, CA4+, revealed differences between healthy 
cartilage af d cartilage at varying degrees of pathology. Though further work is 
required to translate the technique to veterinary use, it offers promise for 
sensitive, minimally-invasive detection of both cartilage lesions and early 
cartilage changes associated with osteoarthritis in the joints of large animals. 
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Contrast-enhanced CT 
(CECT) imaging of intact 
joints on a clinical scanner 
rr·~ 
Disarticulation 
and plug coring 
Joint surfaces for 
image registration 
Plugs for 
further analysis 
GAG assay Contrast enhanced 
~CT imaging 
Mechanical testing 
(E) 
Extraction of clinical CECT Registration of clinical CECT CT imaging of joint 
data fromlplug locations image and coring mask surface (coring mask) 
Figure 7.1: Protocol schematic for equine joint imaging, plug analysis, and 
d . I . ata reg1strahon. 
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(A) 
-160 Hounsfield Units 760 
Figure 7.2: (A) Clinical CECT image following injection of 100 mL of CA4+ 
at 8 mgl/mL (sagittal slice) of the equine femoropatellar joint, where (B) a 
color m Jp rendering shows depth-wise attenuation differences in the 
cartilage. 
(A) 
-160 Hounsfield Units 760 
Figure 7.3: (A) Clinical CECT image following injection of 100 mL of CA4+ 
at 8 mgl/mL (sagittal slice) of the equine femoropatellar joint, showing incomple~e or obstructed diffusion in a large region of both patellar and 
trochlear 1 cartilage. A color map rendering (B) highlights the low 
attenuation (low contrast uptake) in this region). 
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Figure 7.4: (A) CECT attenuation as a function of GAG content for patellar 
and trochlear groove specimens. The relationships for the patella and 
trochlear groove were not statistically significantly different (p = 0.075). (B) 
Example color maps of patellar and trochlear plug specimens shows depth-
wise CA4+ distribution. 
(A) 
650 cr .. l5.12"{;,,c + :N6 
600 
~ 550 
c 
0 50() 
·a 
~ 450 
< 400 
t:i 
1i 350 
] 300 
u 
250 
200 . 
2% 
R'=O.l3 
• 
• CT • lltl!t'CAt. + WI 
• w-~2 
• p • 0.28 
e Patella • Trochlear Groove 
4% 6% 10% 12% 
GAG Content (% of wet weight) 
f!CT Clinical CT 
Plug Volume (ROI Size, mm3) 96 % 
Spatial Resolution (mm) 0.036 X 0.036 X 0.036 0.202 X 0.202 X 0.8 
;: of Voxels per ROI 2,057,613 2.941 
Signal-to- Noise Ratio 2.8 2.6 
Contrast-to-Noise Ratio 3.9 2.4 
(B) Mean CECT Range (HU) 1668 (1773-3441) 315 (295-610) 
Figure 7.5: (A) Correlation between clinical CT attenuation and GAG 
content was weak for the trochlear surface and not statistically significant 
for the patellar surface. (B) Table comparing quantitative differences 
between f-LCT and clinical CT imaging on the equine specimens which may 
impact the quantitative data extracted from each. 
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Figure 7.6: Photographs depicting surgical defects Ml, Ll, and L2 on the left 
trochlea (A) and healthy cartilage on the right trochlea (B). 
Figure 7.7: Clinical CT images showing the locations of the left trochlea 
surgical defects (Ml, Ll, L2) shown in Figure 7.5. Conversely, the intact 
trochlear surface from the contralateral (right) stifle showed undisrupted 
cartilage similar to that shown on the patellar surface above. 
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Figure 7.8: Cartilage GAG content (A), equilibrium compressive modulus 
(B), and ~CT attenuation (C) all corresponded to Outerbridge score. 
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Figure 7.9: Contrast-enhanced ~CT attenuation correlates strongly with 
GAG content (A) and equilibrium compressive modulus (B) for cartilage 
harvested from contralateral equine trochleae. The relationships were not 
signific~ntly different between left and right for GAG content (p = 0.147) or 
modulus (p = 0.150). 
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left and I right trochlea (p = 0.011) whereas the relationship was more 
consistent for equilibrium compressive modulus (B). 
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Chapter : Glycosaminoglycan Quantification in Cartilage via Contrast-
enhanced Computed Tomography Prior to Diffusion Equilibrium 
8.1 Introduction 
S le the conception of contrast-enhanced CT (CECT) of articular 
cartilage, the technique has been applied to a variety of species for the 
quantific tion of glycosaminoglycan (GAG) content and biomechanical 
properties3A,6,s,lo,l3,14,171 . Recently, studies have explored the capability of ionic 
contrast gent partitioning to indicate cartilage properties well before diffusion 
equilibri m. A 2011 study examined whether CECT of cartilage for large 
specimen (human cadaveric knees) may be useful as a tool to evaluate cartilage 
quality69• The study found that clinical CECT attenuation from intact human 
cadaver .Knees following ioxaglate injection correlated strongly with equilibrium 
. . .I f . 1 d . . d h parhhonr g o 10xag ate measure usmg micro-compute tomograp y. 
Interest" gly, this strong correlation (R2 = 0.73) was found after only ten minutes 
of contra t diffusion into the cartilage surfaces. A report from 2012 presents a 
similar r .sulF0• These studies are encouraging for CECT, since in vivo it may not 
, le to reach diffusion equilibrium between articular cartilage and the 
surroun · g contrast agent in the synovial fluid. This is especially true for 
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thicker ca tilage tissues (e.g. from human and horse knee joints), which may take 
too long tiD equilibrate relative to the time scale over which the contrast solution 
effluxes f ~ om the synovial joint space. However, the aforementioned studies 
suggest t at even pre-equilibrium partitioning of an anionic contrast agent could 
yield val able information regarding cartilage quality (glycosaminoglycan 
content , particular, but also possibly tissue permeability, collagen cross-
linking, cbmpressive modulus, etc). To date, the capability of newer cationic 
contrast akents to yield quantitative information regarding cartilage health prior 
to diffusi n equilibrium has not been investigated. Further, CECT using cationic 
contrast akents has been validated in a bovine osteochondral plug model'·"·" and 
has been reliminarily investigated in vivo and ex vivo in rabbits knees (Chapter 
4116), but as not been robustly explored in human articular cartilage. The latter is 
importaJn to address while developing cationic CECT for clinical application, 
since hu an cartilage can differ from these animal models (e.g. human tissue can 
be thick.! and typically has lower water content), Therefore, in this study a 
human osteochondral plug model was used to evaluate the capability of both 
anionic i , xaglate and cationic CA4+ to indicate cartilage GAG content before 
diffusion equilibrium is reached in a simulated in vivo setting. The hypotheses 
were tha 1 1) both contrast agents would produce strong correlations between 
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CECT atte tion and GAG content at equilibrium with CA4+ being more sensitive 
to GAG c 1 ntent, and 2) ioxaglate would produce strong correlations following 
briefer co trast exposure times than CA4+. 
8.2 Matertr ls and Methods 
Fiv human cadaver knee specimens (ages 37, 52, 53, 54, and 79 years) 
were obt ined and thawed at 4 °C (Med-Cure, Portland, OR). Thirty-six 
osteocho ral plugs were cored from the medial and lateral femoral condyles of 
the knees and randomly segregated into three groups of twelve plugs each. The 
circumfer ntial, cut edge of each plug was sealed with cyanoacrylate glue in 
order to estrict contrast diffusion through only the native articular surface, 
re closely resembles the physiologic diffusion scenario compared to 
osteocho dral plug studies in which the cut circumferential edges are exposed. 
Three co trast agent solution baths were prepared (50 mL each); one of anionic 
ioxaglate Hexabrix-320®, Mallinckrodt, St. Louis, MO; diluted 1:4 to 80 mgl/mL) 
f cationic CA4+ (12 mgl/mL and 55 mgl/mL). All contrast agent baths 
a preservative cocktail to prevent nonspecific degradation of the 
cartilage ver the course of the experiment (5 mM EDTA, 5 mM Benzamidine 
HCl, Si a-Aldrich, St. Louis, MO; 1x Gibco® Antibiotic-Antimycotic, Life 
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Technologies, Carlsbad, CA) and each solution was adjusted to pH=7.4 with 
sodium hi droxide and to 400 mOsmol/kg with sodium chloride. An electric 
heater was employed to maintain each contrast agent bath to 34 oc, the typical 
joint temp rature105, and each bath was gently and constantly stirred. Twelve 
osteochon ' ral plugs each were immersed in either ioxaglate or CA4+ at high or 
low concentration (12 mgi/mL or 55 mgl/mL, respectively) and periodic micro-
computed tomography scans were acquired over 2-4 days (flCT40, Scanco 
Medical, ~G, Briittisellen, Switzerland) at an isotropic voxel resolution of 36 fliD, 
70 kVp tuL voltage, 113 flA current, and 300 ms integration time. The CT images 
were coJ erted to DICOM format and imported into analysis software 
(AnalyzeR', AnalyzeDirect, Overland Park, KS), which enabled semi-automatic, 
contour-b sed segmentation of the cartilage from the subchondral bone. The 
mean x-J linear attenuation coefficient of each cartilage plug at each imaging 
time poi t was corrected by subtracting the attenuation of a non-contrast 
(baseline) scan, and then the adjusted linear attenuation coefficient was 
converted to intra-tissue contrast concentration by comparing to a standard 
curve of T anned contrast agent serial dilutions. Following the imaging series, 
each carti age plug was rinsed in a large volume of saline with preservative 
cocktail for 48 hours at room temperature. Then, each cartilage specimen was 
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sharply J ssected from the subchondral bone, weighed, lyophilized, and 
digested · papain (1 mg/mL in 50 mM sodium phosphate, 5 mM EDTA, and 2 
mM dith othreitol, with a pH of 6.8) at 65°C overnight. The 1,9-
dimethyJ ethylene blue assay was used to determine mean GAG content (as a% 
of wet weil ht) for each specimen (Appendix B). 
For each osteochondral plug, the intra-tissue contrast concentration was 
plotted as a function of time. The concentration vs. time data was fit using a 
nonlinear east squares method with a function of the form A*(l-exp (-t/'[)), and a 
time cons ant ('[) was calculated as the time required to reach 63.2% of the 
equilibril contrast concentration in each plug (MATLAB®, MathWorks, 
Natick, l ). A one-way ANOV A with Tukey HSD post-hoc analysis was used 
to comp.l e ' for both concentrations of CA4+ and ioxaglate (SPSS v17.0, 
Armonk, NY). Also for each plug, contrast concentration was plotted as a 
function ' f tissue depth for all imaging time points in order to visualize the 
changing depth-wise contrast agent distribution over time. For each contrast 
agent at ach imaging time point, intra-tissue concentration was plotted as a 
function 1 f GAG content and univariate linear regression was used to model 
their rel tionship. The coefficient of determination (R2) and slope of the 
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regression ere used to compare the goodness-of-fit and sensitivity, respectively, 
for the cor ,elations over time. 
8.3 Result 
For ioxaglate, one of the twelve plugs was discarded due to a persistent 
artifact in the CECT images. For the remaining eleven plugs, the shape of the 
contrast c 1 ncentration profile with depth was similar for all time points (e.g. 
higher contrast concentration in the upper 50% of the cartilage; Figure 8.1). 
Ioxaglate iffused into cartilage with time constant rr = 2.9 ± 1.6 hours (Mean ± 
StDev), anr equilibrated with a partition coefficient KE = 0.61 ± 0.08 (Figure 8.2A). 
Contrast oncentration was inversely proportional to GAG content, and 
correlated well before diffusion equilibrium was reached (Figure 8.2B). The 
goodness-of-fit (R2) between ioxaglate concentration and GAG content increased 
rapidly in the first 5 hours of diffusion, reached statistical significance by 1.5 
hours, and then plateaued at around R2 = 0.60 (Figure 8.3A). Concurrently, the 
slope of , e regression rapidly increased in magnitude (became more negative) 
for the first 2 hours of diffusion, then steadily decreased in magnitude for the 
next 35 hl rs (Figure 8.3B). Contrast concentration did not significantly correlate 
with wate content for any time point (data not shown). 
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For CA4+ at low concentration, four of the twelve plugs (all from one 
individual donor) were discarded due to suspected freezer desiccation. For the 
remaining eight plugs, the concentration profile with depth initially showed 
higher co centration in the upper zones, but began accumulating higher 
concentra ,·on in the deeper zones around five hours of diffusion (Figure 8.4). 
The contr st agent diffused into cartilage more slowly than ioxaglate (rr = 18.9 ± 
10.8 hour ) and equilibrated with a partition coefficient KE = 2.36 ± 0.40 (Figure 
8.5A). Co trast concentration was directly proportional to GAG content, and 
correlated at and near diffusion equilibrium but not at earlier time points (Figure 
8.5B). Th goodness-of-fit steadily increased with time, but much more slowly 
than for i , xaglate (Figure 8.6A). That is, contrast concentration was statistically 
correlated with GAG content only after 39 hours of diffusion. For CA4+, the 
slope of t e regression slowly increased as diffusion equilibrium was reached 
(Figure 8. B). Contrast concentration did not significantly correlate with water 
content fo any time point. 
Fo CA4+ at high concentration, one of the twelve plugs was discarded in 
the analy is (of time constants only) due to extremely slow diffusion ( -Sx slower 
than the ext slowest specimen). The concentration profile with depth initially 
showed h gher concentration in the upper zones, but began accumulating higher 
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concentration in the deeper zones after several hours similarly to the lower 
concentration CA4+ (data not shown). The high CA4+ concentration also diffused 
into cartilt e more slowly than ioxaglate (' ~ 25.2 ± 28.3 hours, which was 
statisticall different than ioxaglate p = 0.020) and equilibrated with a partition 
coefficient KE = 2.27 ± 2.42 (Figure 8.7 A). Both 'C and KE had very large standard 
deviations for high concentration CA4+. Contrast concentration was directly 
proportior l to GAG content at later diffusion times, and correlated near 
equilibriu ' . Additionally, contrast concentration was inversely proportional to 
GAG conL nt at early diffusion time points (Figure 8.7B). The goodness-of-fit 
increased ,· itially as diffusion began, decreased again, and then rose slowly as 
diffusion equilibrium was near (Figure 8.8A). The slope of the regression 
increased · magnitude (became more negative) at early diffusion time points, 
then decreased in magnitude, and finally increased in magnitude again (became 
more posi ive) as diffusion equilibrium was approached (Figure 8.8B). Contrast 
concentra 'ion did not significantly correlate with water content for any time 
point. 
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8.4 Discus . ion 
Ioxaglate diffused into cartilage more slowly than has been previously 
reported fL bovine osteochondral plugs. This is likely owing to the restriction of 
diffusion o the axial direction only, and also tissue differences between bovine 
cartilage. Observing this difference was one of the objectives of this 
study, as as to estimate, by simulating an in vivo scenario, a diffusion process 
more ak' to what might occur in vivo. As expected, ioxaglate concentration 
correlated with GAG content at diffusion equilibrium. Similar to other reports, 
ioxaglate lso correlated at earlier diffusion time points, becoming statistically 
significan as early as 1.5 hours of diffusion69 • This result is important, because it 
suggests hat pre-equilibrium CECT measurements could yield quantitative 
GAG est' ' ates. However, it is important to note that, while correlative to GAG 
content, t e concentration of ioxaglate in the cartilage far prior to equilibrium is 
not meas ring fixed charge density (GAG content) directly, but probably by way 
of a cova iable. For instance, at early diffusion times, contrast partitioning may 
be strong y influenced by tissue permeability, which is likely related to GAG 
content. I deed, ioxaglate appears to partition in proportion to GAG better 
(higher sl pe, or more sensitivity) at pre-equilibrium time points, which calls into 
question hat ioxaglate is actually measuring at these early time points (times at 
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which the agent hasn't even interacted with the majority of the tissue's negative 
charges in the middle and deep zones). The implications of this distinction for 
quantitati e CECT measurements have not yet been adequately investigated to 
date. 
The difference in time constants between ioxaglate and CA4+ seen here 
was heig tened compared to previous bovine experiments with diffusion 
permitted through the circumferential edges (Chapter 3116). This relative 
impedance on the CA4+ diffusion is likely attributable to charge, since the 
molecular eight and size of ioxaglate and CA4+ are very similar. CA4+ bears +4 
charges p : r molecule to ioxaglate' s -1 . Previous experiments also suggest that 
CA4+ difl sion is slow, potentially due to high cationic charge, but there is no 
evidence l f binding to sites in cartilage (See Chapter 5). Since CA4+ diffusion 
appears t I be relatively slower, it is even more imperative that CA4+ produce 
correlatio s with GAG content prior to diffusion equilibrium, since such is 
unlikely t<D ever be reached in a clinical scenario. For clinical imaging requiring 
an intra-a ticular injection, the contrast agent would need to produce meaningful 
correlations within just a few hours in order to be useful. 
Of l ourse, given the results herein, this situation is unlikely. Using low 
concentr.l.on CA4+ (a concentration which provides very good qualitative and 
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quantitati e images at diffusion equilibrium), correlations with GAG content 
were only evident at or very near equilibrium. Also at equilibrium, the slope of 
the correlation was high as reported previously7•13. At early diffusion time points, 
however, here was no relationship between intra-tissue concentration and GAG 
content. 
1 
is finding may be owing to the difference between early- and late-
diffusion <CA4+ profiles in the tissue. At early time points, more CA4+ is present 
in the up~er zones of the cartilage, since those zones interface with the contrast 
agent solJ tion. Also at early times, specimens with higher GAG content likely 
have low l tissue permeability, and hence have lower contrast accumulation at 
early time points. This is directly opposite to contrast partitioning at equilibrium, 
in which tihose specimens with higher GAG content have accumulated a higher 
concentrj on of CA4+. This observation may explain why, for the specimens in 
high concL tration CA4+, an early-diffusion, statistically significant correlation 
was foun1 at 7 hours of diffusion, which showed an invers.e proportionality 
between intra-tissue concentration and GAG content. Subsequently, the 
correlatioj dissolved again as the depth-wise profile changed from higher 
concentrahon in the upper cartilage zones to that in the deeper zones. Indeed, in 
this set l specimens the regression had negative slope for many hours of 
diffusion, only becoming positive (and statistically significant) at approximately 
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60 hours o diffusion. 
A related complication with pre-equilibrium measurements using CA4+ is 
the very 1 rge deviations in time constants ('t). While the standard deviations 
were trul extreme for the high concentration CA4+ group (several plugs had 
barely re~ hed one ' over the duration of the experiment, while some were 
thoroughly equilibrated), both CA4+ groups had very large 't deviations 
compared to ioxaglate. This outcome could have a substantial impact on pre-
equilibrium GAG quantification, and probably played a role in the current 
experime t. That is, at early CA4+ diffusion times, different cartilage specimens 
will have I quilibrated to enormously different extents. The implication of this is 
that, for a measurement taken at any given time point, CA4+ partitioning in a 
series of pecimens may be dictated by different variables to varying degrees. 
This coul ; make quantification of any particular influencer of contrast uptake 
incredibly problematic. In a future experiment, it would be helpful to use 
multiple egression analysis to monitor several variables influencing contrast 
partition· g with time in order to explicate this issue further. 
Th results of this experiment highlight potential issues with translating 
I 
CECT wii cationic contrast agents. However, there are some limitations to this 
study tha , require mention. For one, the sample size for each contrast agent (n=8-
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12) was s all out of practical necessity. This probably led to the lack of 
correlatio between intra-tissue contrast concentration and water content for all 
and all contrast agents, previous reports suggest that water fraction 
influences solute diffusion120• Even within this small sample size, large 
variabiliti s were observed in time constant, and the reasons for these differences 
were not ell accounted for. In a forthcoming experiment, histological sections 
of the spe 1imens will be analyzed for surface fibrillation, tissue thickness, depth-
distributions (via optical density measurements of Safranin-0 
staining), ollagen content and orientation (via polarized light microscopy), and 
collagen arosslinking density (via high performance liquid chromatography). 
Since the lationic contrast agent CA2+ has been shown to diffuse more quickly in 
bovine ar icular cartilage compared to CA4+ (Chapter 5), experiments are 
currently underway which also explore CA2+ diffusion in human articular 
cartilage t determine the diffusion time at which GAG content can be reliably 
quantifie Likewise, since the experiment restricted diffusion to the axial 
direction only, 1-dimensional modelling approaches could be employed to 
calculate an estimated solute diffusivity (D) for each solute in each cartilage 
plugio4,us. 
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Undoubtedly, CECT imaging is a still-developing technique. Though it 
ld I . 11 .d . . . f · d' il 1· cou potentia y prov1 e quantitative m ormation regar mg cart age qua 1ty, 
further ex I eriments are required in order to develop a truly robust method for 
early detection and monitoring of OA. This study provides important insight 
into the fui ther development of cationic contrast agents for CECT in particular. 
~~ ----~----~--~----~---. 
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(A) I (B) Disl•nce from C•oil•ge Surloce (m) x 10., 
· 1: (A) Color map series of one representative plug showing 
I diffusion over approximately 40 hours. Over time, ioxaglate 
tes in the tissue producing a deep purplish-blue in the color maps. 
(B) Intra · contrast concentration as a function of tissue depth for each 
imaging time point. The depth-wise concentration profile maintains a 
similar shape over time with more contrast agent accumulated in the upper 
-50% ofjthe tissue. The overall contrast concentration inside the tissue rises 
with time, and plateaus well below the concentration of the ioxaglate 
solution (red line). 
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Figure 8 2: (A) Uniaxial ioxaglate diffusion in human femoral condyle 
cartilag;r eached equilibrium by approximately 9 hours (T = 2.9 ± 1.6 hours). 
The das~ed gray line represents the concentration of the ioxaglate solution. 
(B) Ioxa~late concentration in cartilage correlates with GAG content at 
diffusiorl equilibrium and prior (three example time points shown). 
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Figure 8 3: (A) Diffusion time-dependent correlation goodness-of-fit (R2) 
between intra-tissue ioxaglate concentration and GAG content. Black * 
indicate times at which the correlation is statistically significant at the p < 
0.05 lev 1. (B) Diffusion time-dependent slope of the regression between 
ioxaglat concentration and GAG content. All lines are displayed for visual 
purpose only. 
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Figure 8 I (A) Color map series of one representative plug showing CA4+ 
over approximately 70 hours. Over time, CA4+ accumulates in the 
tissue a deep blue in the color maps. (B) Intra-tissue contrast 
concentration as a function of tissue depth for each imaging time point. The 
depth-w·lse concentration profile is skewed towards more superficial 
cartilage at early time points, towards middle-deep zone cartilage at later 
time poiy ts, and plateaus well above the concentration of the CA4+ solution 
(red line). 
50 50 + 30 minutes + 5 hours + 48hours 
:E 45 -45 
.§ 40 to • • :l, :l, ( ,._, ·rtt>":' r-•CA<i•:JU 
~ 35 ~ : • • M' • O.<I ~ 30 • p•IJ.IIO'I 
.5 . 5 • 
C"IW" "' il~~·t;,\l, • ILI"' 
§ 25 c25 R1 • 0.0J r Avcug~t tim~rlo 0 , ...... ~ 20 "' ~Wiibrium: ~20 • c J•'t • 56.6hou~ 
" 
• ~IS ~IS • c 
• 0 0 • • u 10 't = 18.9 ± 10.8 hours UJO • .;l; + 
" 
!Ill 
< 5 K, ~ 2.36 ± 0.40 < 5 • ,. "' u u 
• • • 0 
10 20 30 40 50 60 7o (B) o.oos o.o1s o.o25 o.o35 (A) Diffusion Time (hours) GAG Content (mg/mg wet weight) 
Figure 8.5: (A) Uniaxial CA4+ (12 mgl/mL) diffusion in human femoral 
condyle b rtilage reached equilibrium by approximately 57 hours h = 18.9 ± 
10.8 hout s). The dashed gray line represents the concentration of the CA4+ 
solution (B) CA4+ concentration in cartilage correlates with GAG content at 
and nea diffusion equilibrium but not prior (three example time poin ts 
shown). 
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near dif~usion equilibrium (direct proportionality) and for one time point 
prior (in erse proportionality). Three example time points are shown. 
134 
0.7 
= l 0.6 
~ 0.5 
~ 
-= 
-a 0.4 
~ 
:: 0.3 
ii: 
'$ ~ 0.2 
= ., 
g 0.1 
'-' 
• 
• 
,.. 600 
,.. 
= 200 
l 
~ -200 
~ 
= 
" ~ -600 • 
y; 
-1000 
~ 40 60 80 (A) Diffusion Time (hours) (B) -1400 
,.. 
• iii 
• 
• 
20 40 60 80 
Diffusion Trme (hours) 
• 
• 
• 
Figure .8: Diffusion time-dependent correlation goodness-of-fit (R2) 
between I intra-tissue CA4+ concentration and GAG content for cartilage 
enhance4 with CA4+ at 55 mgl/mL. Black * indicates times at which the 
correlatidn is statistically significant at the p < 0.05 level. (B) Diffusion 
time-dep~ndent slope of the regression between CA4+ concentration and 
GAG co:d.tent. All lines are displayed for visual purposes only. 
135 
Chapter 9• An Interpenetrating Hydrogel for Reinforcing Cartilage at Early 
Degenerative States 
9.1 Introd ction 
For nearly all patients, osteoarthritis (OA) diagnosis is rendered at a late 
stage of t e disease. Being a progressive, degenerative process, diagnosed OA 
has alrea y been developing within a patient's articular joint for years or 
decades. r though this development window can be quite lengthy, two critical 
shortcoml gs preclude preventative OA care. One, of course, is the general 
inability ~ physicians to diagnose OA at its earlier stages. The main aim of 
contrast-elilianced computed tomography (CECT) is to fill this unmet need. 
Companion therapies for early-stage OA, however, must also immediately 
follow ot lerwise early diagnosis will have minimal utility. The second current 
inadequacy in OA care is the lack of treatments for alleviating or halting OA 
progressii i . As many disorders are exceptionally sensitive to early-stage 
interventi 'ns, early intervention in OA, in the form of reconstituting lost 
glycosaml oglycan (GAG) content, could have a substantial positive impact on 
patient j tcomes. Although many tissue-engineered strategies for cartilage 
repair exil t"-"·" ·" ·" ·86·"·"'·" ·'"·"' (an exhaustive list would indeed be exhausting), 
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most strat gies focus on defect repair and improved healing. Currently, there are 
no clinical[y utilized biochemical or materials-based therapies that either a) 
significant y mitigate GAG loss, or b) effectively replace lost GAG with a natural 
or syntheti substitute. 
To eet this need, a novel tissue-supplementing technique was developed 
in which GAG-mimetic hydrogel is polymerized in situ throughout cartilage 
tissue. AI alogous to strategies for strengthening synthetic hydrogel 
networks1 ,178, biologically-inspired polymer networks179, and biomolecule-
derived 14olymer networks180 by incorporating an interpenetrating second 
network, the hypothesis was that small monomers possessing water-
immobiliz g charged functional groups could be diffused into GAG-deficient 
cartilage, ' olymerized, and would result in formation of a cross-linked hydrogel 
that mimi<rs the mechanical contribution of GAGs in . cartilage. Precise structural 
mimicry + GAG, with its abundant negative charges, would prove challenging 
as negativ~ly charged monomers are strongly electrostatically repelled from the 
tissue. Pof tively charged monomers, in contrast, are electrostatically attracted to 
and can dr fuse into the tissue in high proportions. However, a strategy relying 
upon cati~nic small molecules may be problematic as many elicit undesirable 
immune eactions at the relatively high concentrations required to produce a 
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hydrogel ith sufficient mechanical integrity. Thus, in this study the ability of a 
zwitterionic (i.e. containing both positive and negative charges, with net neutral 
charge p r molecule) monomer to produce a mechanically-reinforcing, 
interpenet ating network (lPN) within articular cartilage was investigated. 
9.2 Materi ls and Methods 
Ostr ochondral plugs (n=20, 7 mm diameter) were cored from the trochleae 
of four ad lt cow knees (aged 1-4 years). A randomly selected subset of the plugs 
(n=10) wee enzymatically degraded with chondroitinase ABC (0.5 U/mL in 
buffer co! taining 50 mM Tris, 60 mM sodium acetate, 0.02% bovine serum 
albumin, ' H=8.0 for 24 hours at 37oC) to selectively deplete cartilage GAGs. This 
"degraded" group served as a model for early-stage OA compared to the un-
degraded l ontrols. 
easure pre-IPN mechanical performance of the plugs, each plug was 
rigidly cl mped in a mechanical testing apparatus (Enduratec3230, BOSE, Eden 
Prairie, N) and a compressive pre-load of 5 N was applied between the 
cartilage urface and a nonporous UHMWPE platen to ensure complete contact 
between he cartilage and platen. While immersed in saline, each plug was 
subjected o 4 incremental 5% compressive strain steps (5 ~J.m/sec) in unconfined 
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compressi n with stress relaxation (45 minutes) between strain steps. A 
collection rate of 10 Hz was used to record the force and displacement data, and 
a linear fi[ to stress vs. strain at each equilibrium was used to calculate the 
equilibriu , compressive modulus (E, MPa) for each cartilage specimen. 
Additiona ly, the stress relaxation period following the 10% strain was modelled 
using nonlinear least squares regression to a bimodal decay curve of the form 
A *(1-exp 1-t/'tfast) )+ B*(1-exp ( -t/'tsiow) )+C in order to derive stress relaxation time 
constants fast and 'tslow. 
Fol owing mechanical testing, the plugs were recovered in saline at 4°C 
overnight and then the interpenetrating network (lPN) treatment was applied. 
The zwit~erionic monomer 2-methacryloyloxyethyl phosphorylcholine (MPC), 
exhibitinJ no overall molecular charge yet possessing charged phosphate and 
trimethyJ mmonium functional groups, was selected as it is known to 
demonsJ te biocompatibility'"-'83 and a high degree of hydration'", even under 
extreme aompressive loads185-187• The plugs were incubated in the dark for 24 
hours in solution containing MPC concentrations at either 20, 40, or 60 w/v%, 
ethylene glycol dimethacrylate (EGDMA) as a crosslinking agent, and a 
photoinitiating system composed of eosin Y, triethanolamine, and N-vinyl 
pyrrolid e188•189• Plugs were then removed from solution, irradiated with a non-
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damaging tissue-penetrating wavelength of laser light (514 nm, 500 mW/cm2, 10 
minutes; l!Jltima 2000 SE Argon Laser, Coherent Medical Group, Santa Clara, 
CA), and insed in saline overnight at room temperature to allow residual non-
reacted monomer to wash out. Following rinsing, the mechanical testing regimen 
was repet ed and E, "'"and ""o• were compared to pre-treatment values using 
paired sa ples t-tests (SPSS v.17.0, IBM, Armonk, NY). · 
In a small follow-up experiment, four human osteochondral plugs 
harvested from the tibiae of four adult human knees were also treated at 20 
w/v% M ' C solution and the previously described reaction conditions. Pre-
treatment and post-treatment mechanical testing was performed as described 
above, b t the strains were applied at 0.333%/sec (controlled strain rate) rather 
m/sec (controlled displacement rate). Additionally, pre-treatment and 
post-treafunent contrast-enhanced computed tomography (CECT) of each plug 
was perfL med by immersing each plug for 24 hours in a 60 mgl/mL solution of 
the noniL ic, iodinated contrast agent iohexol (OmnipaquerM, GE Healthcare, 
Fairfield, CT). Following equilibration in the contrast agent solution, the plugs 
were imaged (!-!CT40, Scanco Medical AG, Briittisellen, Switzerland) at an 
isotropic oxel resolution of 36 1-1m, 70 kVp tube voltage, 114 1-1A current, and 300 
ms integ ation. The cartilage CECT attenuation for both pre- and post-treatment 
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images were determined by segmenting the cartilage from the subchondral bone, 
convertin~ the sampled linear attenuation coefficients to Hounsfield Units (HU), 
and correating by subtracting the non-contrast cartilage attenuation. For both 
pre- and p st-treatment, the iohexol partition coefficient, K, was calculated as the 
ratio bet een equilibrium cartilage CECT attenuation and iohexol solution 
attenuation. 
9.3 Results 
HeL hy bovine cartilage plugs treated with a monomer concentration of 
20 w/v% l derwent an average increase in E from 0.31 ± 0.02 (Mean± StdDev) to 
0.41 ± 0 04 MPa while degraded plugs treated at the same monomer 
concentralion increased from 0.22 ± 0.01 to 0.40 ± 0.01 MPa, corresponding to 
statistical y different (p = 0.031 and p = 0.007, respectively) increases in modulus 
(32% ± 1 % and 80% ± 15%, respectively (Figure 9.1)). A similar trend was 
observed at increased treatment concentrations as well; following 40 w/v% 
treatmen E of healthy plugs increased to 0.73 ± 0.18 MPa (72% ± 12% increase, p 
= 0.001) d that of degraded plugs increased to 0.58 ± 0.06 MPa (108% ± 9% 
increase, p = 0.002). Following 60 w/v% treatment, E of healthy explants 
increase to 0.97 ± 0.41 MPa (121% ± 42% increase, p 0.036) and that of 
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degraded xplants increased to 1.72 ± 0.56 MPa (286% ± 47% increase, p = 0.009). 
That is, e ery plug had increased E following IPN-treatment, with degraded 
plugs con, istently showing higher percent increases in E compared to healthy 
controls (Jigure 9.1, diamonds on secondary y-axis). 
Ad~itionally, the IPN-treated cartilage plugs exhibited consistently longer 
relaxatio~ time constants ( 'Ifast and 'Islow) during the stress relaxation regimen. This 
I 
was the ase for every plug, and there appeared to be a trend towards more 
substanti 1 increases in time constants with higher w/v% treatment conditions 
(Figure 9. ). However, it was not clear whether GAG-depleted plugs experienced 
a larger · crease in time constants compared to control plugs. 
In a small series of human osteochondral plugs, a 20 w/v% treatment did 
not consistently change E (Figure 9.3) but did increase both 'Ifast and 'Islow while 
decreas1 g ioxhexol partition coefficient (K) (p = 0.022, p = 0.021, and p = 0.002, 
respective! y) . 
9.4 Discussion 
In the bovine experiment, supplementation of cartilage with an 
interpen trating MPC-based hydrogel improved the tissue's compressive 
stiffness in a dose-dependent manner. Additionally, GAG-depleted cartilage 
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underwen a greater percent increase in E compared to controls for each w/v% 
treatment. That GAG-depleted plugs experienced a larger modulus 
reinforce, ent suggests that the monomer may preferentially localize to tissue 
that is degraded (perhaps owing to a higher water volume fraction). Therefore, a 
finely-tun~d treatment protocol may enable the lPN to behave as a "smart" 
polymer {hat increases tissue stiffness in proportion to its degenerative state. 
Such a J eatment scheme could be convenient and efficacious for repairing 
cartilage surfaces, which contain focal degeneration. For instance, joint 
malalignment or traumatic injury can cause some tissue regions to degenerate 
faster thl others, creating a joint surface with regions of varying mechanical 
propertie (stiffness, coefficient of friction, etc.); this mismatch among adjacent 
tissue re~ons further hastens cartilage deterioration. Ideally, a "smart" polymer 
treatment would be applied to the whole surface and provide locally-suitable 
ts in mechanical properties. 10 
treatment consistently slowed stress relaxation at the 10% strain step. 
Unfor ately, in this experiment the compression tests were performed with a 
controlle displacement rate rather than a controlled strain rate, and therefore it 
is tenuo s to directly compare relaxation time constants from plugs of differing 
thickne.les. For this reason, statistical analyses of the time constants have been 
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omitted. S ·ll, the trends in time constants suggest that the increase in both 'tfas t 
and ' •'= r s dose-dependent, with particularly large differences for 60 w/v%. 
Arj ficially GAG-depleted bovine cartilage is a common experimental 
model fl' osteoarthritic tissue, but cartilage in human OA is both 
compositii nally different and more diverse compared to bovine tissue harvested 
from you g, healthy animals of all the same age. Therefore, the lPN technique 
pplied to human tibial plateau cartilage to evaluate the technique's 
efficacy· reinforcing naturally GAG-depleted, early-OA tissue. That the human 
cartilage ~ reated at 20 w/v% did not show a consistent increase in E may be 
owing to the more complexly compromised extracellular matrix (ECM) in the 
human pl gs. That is, in the bovine model GAG-depletion was performed with a 
selective .nzyme, which does not disrupt the remaining ECM components, while 
the humi i OA samples were harvested from adult human knee cartilage, some 
of which howed early signs of degeneration (minor to moderate fibrillation and 
softening1' · Given these results, a subsequent hypothesis is that lPN efficacy is 
partially ' ependent upon the presence of the structural support conferred by the 
collagen [I atrix in cartilage. Specifically, the fibrillated cartilage in the human 
samples ay not provide a sufficient scaffolding for hydrogel formation at 20 
w/v%, lhich resulted in a relatively weak lPN. Since this initial trial was 
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performed using only 20 w/v%, it is unknown (though very likely) that a higher 
w/v% trea ment would result in stronger lPN. Clearly, the treatment scheme will 
need to b re-tuned for use in human tissue. Interestingly, however, consistent 
increases both time constants with a concurrent, similar in magnitude, 
decrease 1 iohexol K were observed. Potentially, all three findings are owing to 
the hydro ynamic impact of lPN treatment. For instance, the increase in time 
constants may be explained by either 1) the hydrophilic lPN treatment 
restrainin fluid flow within the tissue, or 2) the treatment reduced the water 
volume fraction in the tissue. Further experiments that address the IPN-induced 
changes i both water volume and fluid flow in cartilage plugs are underway. 
For the co trast partitioning measurement, the nonionic contrast agent iohexol 
was select . d because its partitioning in cartilage should be mostly influenced by 
the tissue' permeability (rather than fixed charge density, as with anionic and 
cationic c ntrast agents partitioned at equilibrium). In this experiment, the 
circumfer .ntial edges of the plugs were left exposed, and so 24 hours of diffusion 
for iohex<i>l was expected to be sufficient for equilibration. That post-IPN 
treatment was significantly lower suggests two possibilities as well, that 1) the 
post-treat ent plugs had not reached equilibrium, portending slowed solute 
diffusion, or 2) the post-treatment plugs were equilibrated but had less iohexol 
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uptake due to reduced tissue water volume. These possibilities will also be 
investigated in future experiments. 
There are several limitations to the present study. The human plug subset 
is very small in sample size, and should be repeated with varying w/v% 
treatments. In the bovine study, time constants were difficult to compare due to 
uncontrolled strain rates; this issue was corrected for the human experiment. 
Additionally, more thorough tissue characterization both before and after IPN 
treatment is warranted and will be conducted in future experiments. Measuring 
tissue water content, hydraulic permeability, dynamic compressive moduli, 
shear moduli, coefficients of friction, and solute permeability are all important 
for fully characterizing the impact of IPN treatment. In particular, a more 
focused investigation of the response of IPN-treated cartilage to dynamic 
compression will be more physiologically relevant than the equilibrium stress-
relaxation measurements conducted here. Also, IPN performance during and 
after accelerated wear regimens could provide insight into how the treated 
cartilage behaves during cyclic loading akin to what would be applied in vivo. 
Finally, the investigation of these in a broad range of healthy and OA human 
cartilage specimens is critical for finely tuning treatment parameters in order to 
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achieve cartilage mechanical performance, which approximates that of healthy 
tissue. 
In sum, the results herein are encouraging. That an lPN treatment might 
restore the inferior performance of GAG-depleted cartilage in a "smart" or self-
adjusting way is promising as a materials-based treatment for this widespread 
and debilitating disease. 
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Figure 9.1: Bovine cartilage equilibrium compressive modulus (E) pre- and 
post-treatment with different w/v% monomer concentrations. * p < 0.05, ** p 
< 0.01. Percentage annotations indicate the increase in E (mean ± stdev) for 
each group following lPN treatment. 
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Figure 9.3: IPN-treated (20 w/v%, n=4) human articular cartilage did not 
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Chapter 10: Summary 
Through the studies presented herein, a contrast-enhanced computed 
tomography-based diagnostic technique was developed for osteoarthritis as well 
as an early therapeutic strategy centered upon a glycosaminoglycan-mimicking 
hydrogel. These studies were driven by three overarching hypotheses, the first of 
which is that cationic contrast agents will be highly taken up in cartilage and will 
enable sensitive quantification of glycosaminoglycan content as well as 
biomechanical properties of cartilage using high-resolution CT instrumentation. 
Cationic agents are highly taken up in cartilage due to electrostatic attraction, but 
possess negligible binding affinity for sites in cartilage. Rather, cationic contrast 
agent uptake in cartilage follows the predictions of Donnan equilibrium theory. 
A specific cationic contrast agent, CA4+, was highly taken up in cartilage in an in 
vivo rabbit model. In vivo imaging using both CA4+ and ioxaglate, a 
commercially available anionic contrast agent, were correlated with ex vivo 
measurements acquired at diffusion equilibrium. These findings suggest that 
both agents may be effective for indicating cartilage quality differences in vivo in 
small animal models. Through imaging studies using human hip and knee 
articular cartilage as well as equine stifle cartilage, both glycosaminoglycan 
content and equilibrium compressive modulus can be robustly quantified using 
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high-resolution micro-computed tomography. Clinical CECT is able to replicate 
these results to a degree, but complications such as scanner spatial resolution 
limit quantification ability. Additionally, the cationic contrast agent CA4+ 
diffuses into cartilage much more slowly than anionic contrast agents, and it also 
does not yield quantitative imaging prior to diffusion equilibrium. An anionic 
agent, ioxaglate, does yield quantitative information prior to diffusion 
equilibrium. Several similar reports in the literature underemphasize the proper 
interpretation of these results-that is, although anionic contrast agent 
partitioning correlates with glycosaminoglycan content prior to diffusion 
equilibrium, it is not, in these instances, measuring fixed charge density directly, 
but rather a more complex set of factors related to cartilage tissue composition 
and structure. Further study of these specific variables, aside from 
glycosaminoglycan content, is warranted in order to best design CECT for 
quantitative cartilage imaging. 
To add a broader context to the diagnostic work, a novel osteoarthritis 
treatment strategy was developed and validated which addresses early-stage 
disease features-namely, glycosaminoglycan depletion and tissue softening. 
The driving hypothesis was that an interpenetrating, glycosaminoglycan-
mimicking hydrogel network will restore the mechanical function of degraded 
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cartilage to that of healthy tissue. Indeed, the interpenetrating network strategy 
did increase compressive stiffness of both healthy and degraded cartilage, with 
stronger effect for degraded cartilage. Hence, the therapy could potentially be 
developed as a "smart" polymer, which preferentially stiffens cartilage (by 
replacing lost glycosaminoglycan functionality) that is osteoarthritic. 
Future work leading from these studies are many, both in regard to the 
diagnostic technique and the therapeutic strategy. In particular, similar cationic 
contrast agents with faster diffusion profiles should be evaluated. The efficacy of 
cationic contrast agents in CECT of small animal models should be more robustly 
investigated, since it is likely that thin cartilages (which achieve diffusion 
equilibrium very quickly) will be more easily quantitatively assessed. Likewise, 
the interpenetrating, glycosaminoglycan-mimicking hydrogel strategy should be 
more finely tuned to meet the needs of human cartilage in early osteoarthritis. 
In sum, both a diagnostic technique and therapeutic strategy for early 
osteoarthritis were developed and investigated, revealing both strengths, 
weakness, and yet-to-be-investigated elements for each. Future work in the 
Grinstaff Group at Boston University will attend to both efforts, with an overall 
motivation to provide better clinical care to patients suffering the burden of 
osteoarthritis. 
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Appendix A: Synthesis of Cationic Iodinated Contrast Agents and Cationic 
Non-Iodinated Analogs 
The synthesis of cationic iodinated contrast agents has been previously 
reported12• Briefly, CA2+ and CA4+ were both synthesized in four steps from a 
commercially available tri-iodinated precursor, 5-Amino-2,4,6-triiodoisophthalic 
acid (Figure A.l). The appropriate acyl chloride was generated using published 
protocols, then reacted with a mono-Boc protected ethylenediamine, and 
subsequently deprotected with hydrochloric acid to afford the desired primary 
amino compounds. The final contrast agents were soluble at concentrations up to 
0.2 M in aqueous solution and bore positive charges, by virtue of their primary 
amine substituents, at pH=7.4. 
For diffusivity measurements, non-iodinated contrast agent analogs 
(CA2+01, CA4+01) were synthesized via a similar protocol. The starting material 
was instead the non-iodinated 5-Aminoisophthalic acid, and yielded analogs that 
were structurally similar, though approximately 50% of the molecular weight, of 
the cationic iodinated contrast agents (Figure A.2). 
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Figure A.l: Synthetic scheme for the cationic iodinated contrast agents CA2+ 
and CA4+. Reagents and conditions: (a) SOCh,.::\; (b) AcCl, DMA; (c) DMA, 
DIPEA; (d) CH2Cl2/HC1; (e) THF, .::\. 
CA2+ 
MW=685.9Da 
CA2+01 
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Figure A.2: Comparison of the chemical structures of CA2+ and CA2+01 
(left) as well as CA4+ and CA4+01 (right). The non-iodinated analogs 
(bottoms) had approximately 55% smaller molecular weights (MW) 
compared to the iodinated contrast agents. 
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Appendix B: Biochemical Determination of Glycosaminoglycan Content in 
Cartilage Specimens: Protocol Details on the 1,9-Dimethylmethylene Blue 
(DMMB) Assay 
The 1,9-dimethylmethylene blue (DMMB) assay19D--192 is a colorimetric 
assay for determining the total mass of sulfated glycosaminoglycans (GAGs) in 
tissue specimens. Throughout this volume, the DMMB assay is frequently used 
to biochemically quantify GAG content in cartilage as a means for validating that 
contrast agent partitioning reflects GAG content. The assay has been in use, in 
particular for quantifying GAG in cartilage specimens, for several decades and is 
widely used in the field. It is based on the metachromatic absorption shift in 1,9-
dimethylmethylene blue, a potent cationic dye, as it specifically binds to sulfated 
glycosaminoglycans. The specific protocol used in the experiments presented 
herein follows: 
Articular cartilage specimens were carefully separated from the 
subchondral bone using a #11 blade scalpel. Care was taken to remove all of the 
cartilage tissue, including the entire deep zone. The wet mass of the cartilage 
was measured using a microbalance (Mettler Instrument Corp., Highstown, NJ), 
and the cartilage was flash-frozen in liquid nitrogen and lyophilized to dryness 
(24-48 hours). Subsequently, the cartilage specimens were digested in papain (1 
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mg/mL in buffer containing 50 mM sodium phosphate, 5 mM EDT A, 2 mM 
dithiotreitol, pH 6.8) at 65°C for 24 hours. The digested solutions were then 
diluted, in buffer, 10 to 80 times for the assay. A linear standard curve was 
generated using chondroitin-4-sulfate (Sigma-Aldrich C4384, St. Louis, MO) 
dissolved in the same buffer at concentrations ranging from 10-100 ~g/mL. 10 
~L of each chondroitin-4-sulfate standard solution or sample digestion solution 
was mixed with 100 ~L of DMMB dye solution (38.5 ~M 1,9-dimethylmethylene 
blue zinc chloride salt, Sigma-Aldrich 341088; 40.5 mM glycine, 46.7 mM sodium 
chloride, 0.5% ethanol in deionized water, pH=3.0) in a 96-well plate. The 
absorbance of each solution at 520 nm was acquired immediately after mixing 
using a plate reader (Beckman Coulter AD340, Fullerton, CA). Each cartilage 
digestion solution was assayed in triplicate and averaged. The total GAG mass 
for each specimen was calculated by comparison to the standard curve and was 
reported as total mg GAG mass per mg cartilage wet mass (GAG as a% of wet 
mass) for each specimen. 
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